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 The goal of this dissertation was to explore the response of broiler chickens to dietary D3 
(vitamin D3) and 25-OH-D3 (25-hydroxycholecalciferol) as well as to establish a protocol that 
precisely estimated the D3 requirement of modern meat-type chickens through an oral gavage 
bioassay. For this purpose, three research projects were conducted. For the first and second 
experiments, broiler chickens were fed a diet devoid of D3 for 21 d. The first 9 d of the study 
served to deplete the maternal stores of D3. On d-10 of the study, a crystalline source of D3 was 
diluted in corn oil to prepare graded levels of D3 that were directly gavaged into the crop of birds 
for 11 d. Broken-line regression was employed to estimate the requirement of D3 for maximum 
bone mineralization. The first experiment fed a mash corn-soy diet with reduced calcium and 
non-phytate phosphorus. The second experiment fed a corn-soy diet as well but as crumbles, and 
all nutrients met or exceeded industry-type nutritional requirements. The D3 requirement of 
starter broilers was estimated in experiment-1 to be close to the 500 IU/kg of feed and in 
experiment-2 to be around 200 IU/kg of feed for maximum bone mineralization. I concluded that 
nutrient restrictions increased the D3 requirement with respect the NRC (1994), and that maternal 
D3 stores in the yolk highly influenced the growth performance and bone mineralization response 
of broiler chickens to dietary D3. Using industry-type nutritionally adequate diets, the dietary D3 
requirement appears to be in agreement with the NRC (1994).   
In the third experiment, broiler chickens were subjected to a coccidiosis vaccine 
challenge and fed dietary concentrations of D3 or a partial replacement of D3 with 25-OH-D3. 
Results suggested that the combination of both D3 and 25-OH-D3 was more effective than D3 




plasma 25-OH-D3 in young (21 d-old) broiler chickens. Additionally, the supplementation of 
high dietary levels of D3, independently of the source, above NRC (1994) recommendations, 
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CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW 
 
INTRODUCTION 
 According to the United Nations (2017), the global inhabitants are expected to reach ≈9.8 
billion by 2050. Along with the increasing population, food supply from vegetal and animal 
origin will play a key role in preventing food insecurity around the world and especially in 
developing countries where poverty is still one of the biggest obstacles to overcome. Therefore, 
to increase the availability of animal protein at reasonable cost, production systems need to 
increase their efficiency and sustainability.  
 Since the early 1960’s the commercial poultry industry has worked intensively in diverse 
areas such as, genetics, nutrition, flock management, feed technology, and immunology to 
promote efficiency and reduce production costs. As a result of these efforts, meat-type chickens 
have experienced an accelerated increase in growth rate (Havenstein et al., 2003). The 
accelerated growth continues through the present day and has led to higher meat yields and better 
feed efficiency when compared to the 1960’s meat-type chickens. However, there are problems 
associated with the improvement in growth rate. Skeletal disorders, due to intensive genetic 
selection towards higher meat yields, are an example. Nutritional inadequacies leading to bone 
deformities and diseases have been a subject of concern among nutritionists and welfare experts 
(Edwards, 2000; Waldenstedt, 2006; Kapell et al., 2012). Bone health is an important component 
of animal welfare and therefore has a direct relationship with the bird’s performance. Annual 




for broiler chickens (Morris, 1993; Sullivan, 1994) which, adjusted to the annual inflation (U.S. 
Bureau of Labor Statistics), would represent $134 to $200 million USD in 2017.  
 A common nutritional strategy used to reduce the incidence of skeletal disorders, such as 
tibial dyschondroplasia or rickets, has been the supplementation of poultry feeds with vitamin D3 
(D3) and more recently, derived metabolites like 25-hydroxycholecalciferol (25-OH-D3) 
(Ledwaba and Roberson, 2003; Waldenstedt, 2006). Vitamin D3 is known for its role in the 
regulation of calcium (Ca) and phosphorus (P) homeostasis in conjunction with calcitonin and 
parathyroid hormones (Collins and Norman, 2001) which ultimately, promote bone health.  
 International units (IU) are used to express the biological activity of vitamin D. One IU 
of vitamin D is defined as the activity of 0.025 μg of crystalline cholecalciferol. The NRC (1994) 
established the D3 requirement at 200 IU/kg of diet for starting growing broiler chicks. However, 
current industry-type poultry diets are supplemented with 10 or even 30 times the NRC (1994) 
recommendations (Leeson, 2007). Post NRC (1994) research done on high dietary D3 effects on 
meat-type chickens reported beneficial effects on growth, bone health (Kasim and Edwards, 
2000; Fritts and Waldroup, 2003; Whitehead et al., 2004; Rama Rao et al., 2006; Khan et al., 
2010), and avian immunity (Aslam et al., 1998; Morris and Selvaraj, 2014; Morris et al., 2015). 
It is probable that modern poultry strains have altered their ability to utilize dietary nutrients after 
24 years of intensive genetic selection (Havenstein et al., 2003; Schmidt et al., 2009; Applegate 
and Angel, 2014). Additionally, nutritionists rely on literature references such as the NRC to 
formulate diets that precisely meet the animal’s nutritional requirements. Hence, it is necessary 
to develop new protocols that more accurately reflect current feeding strategies and the ability of 
modern poultry strains to respond to dietary nutrients such as vitamin D3. Furthermore, the effect 




among the commercial poultry industry. Nutritionists are actively seeking for possible dietary 
“alternatives” to antibiotic growth promoters and ways to enhance animal well-being through 
nutrition (Ferket, 2004). 
 The goal of this research project was to explore the response of modern broiler chickens 
to dietary D3 and 25-OH-D3 as well as to establish a protocol that precisely estimated the D3 
requirement of meat-type chickens through an oral gavage bioassay. Thus, this research project 
was conducted with the following objectives: 1) evaluate the effects of high dietary levels of D3 
and 25-OH-D3 on performance, bone mineralization and intestinal morphology of growing 
broiler chickens; 2) evaluate the effects of high dietary levels of D3 and 25-OH-D3 
supplementation on broiler plasma cytokine levels after a coccidia vaccine challenge; 3) compare 
broiler growth response to supplemental D3 alone versus supplemental D3 in combination with 
25-OH-D3; 4) identify optimal supplemental levels of D3 and 25-OH-D3 to maximize 
performance, bone mineralization, intestinal morphology and immune response of broiler 
chickens; 5) re-evaluate the D3 requirement for starter broiler chickens using a non-traditional 
methodology to deliver D3 to the chickens; 6) compare D3 requirements of modern broiler strains 
to those reported by the latest Poultry NRC (1994).   
   
LITERATURE REVIEW   
Cholecalciferol “The Sunshine Vitamin” Overview 
 Vitamin D is a fat-soluble vitamin known for its anti-rachitic activity in humans and 
animals. The early study of vitamin D dates back to the 18
th
 century, during the industrial 
revolution, when the incidence of rickets among young children became a health problem known 




started to investigate the factors that possibly caused rickets. Many factors were described as the 
cause of rickets such as, lack of fresh air or sunlight, congenital factors, age, infectious agents, 
lack of physical activity and malfunction of endocrine glands were described as possible factors 
predisposing the incidence of rickets (Norman, 1979). In 1919, Edward Mellanby undertook 
studies of the recently identified vitamin A in cod liver oil, which was recognized to prevent 
xeropthalmia and night blindness, to study the relationship of rickets and nutritional factors or 
vitamin factors. He conducted several studies using dogs fed low-fat diets trying to develop an 
animal model for rickets. Mellanby observed a potent antirachitic activity in the cod liver oil and 
concluded that a vitamin A deficiency will cause a higher incidence of rickets. McCollum (1922) 
who previously identified the nutritional importance of vitamin A, believed a different 
compound was responsible of the antirachitic activity of the cod liver oil. After he destroyed 
vitamin A in cod liver oil using oxygen and heat, the treated oil was fed to rachitic rats and 
chicks who successfully recovered from rickets. It was clear that a different compound was 
responsible of curing rickets, and he named it vitamin D.  
 A few years later, Goldblatt and Soames (1923) and Steenbock and Black (1925) 
established the fundamental relationship between UV-light and vitamin D. The chemical 
structure of vitamin D3 was determined years later by the German chemist, and Nobel Prize 
winner Adolf Windaus in collaboration with his research group in 1936 (Collins and Norman, 
2001). However, it was until the 1970´s when Kodicek et al. (1970), DeLuca (1978), Norman 
(1979) and other scientists clearly defined vitamin D’s metabolic role and its importance in 
human and animal nutrition.  
 Two main forms of vitamin D have been described, ergocalciferol (D2) or vitamin D2 and 




distributed in plants, fungi and molds while cholecalciferol is present in animals where vitamin 
concentration depends on dietary D3 and exposure of the tissue to sunlight (Combs, 2012). 
Vitamins D2 and D3 have relatively the same bioactivity for cattle, sheep and pigs. However, in 
the case of poultry, D2 has only 10% the bioactivity of D3 (McDonald et al., 1995). Therefore, D3 
supplements are preferred to formulate commercial poultry vitamin premixes. 
 Vitamin D3 is soluble in organic non-polar solvents and oils; it has a melting point of 84-
85°C, maximum UV absorption is between 254-265 nm and can be destroyed by excess 
irradiation of UV-light and when exposed to air at 24°C for 72 h (Collins and Norman, 2001).   
 Vitamin D3 is obtained from the diet or is synthesized in vivo from the provitamin 7-
dehydrocholesterol in the epidermal layer of the skin after exposure to UV-light. Dietary and 
endogenous synthesized D3 are considered biologically inactive and must undergo activation 
through hydroxylation reactions in the body. First, D3 is transported via the blood to the liver 
where it is converted to 25-OH-D3, the major circulating form of D3. The newly formed 25-OH-
D3 must then be transported to the kidneys for conversion into 1, 25-dihydroxycholecalciferol (1, 
25(OH)2 D3) which is the fully active hormonal D3 metabolite (Norman, 1979). Vitamin D 
participates in the regulation of calcium and phosphorus homeostasis to assure proper metabolic 
functions and promote bone development (Collins and Norman, 2001). Calcium is important for 
bone formation and development; it is also required for proper nerve impulse transmission and 
muscle contraction (Leeson and Summers, 2001). Phosphorus is considered an essential nutrient 
for normal bone development, muscle coordination, energy, carbohydrate, amino acid and fat 
metabolism, nervous tissue metabolism, normal blood chemistry, and is a structural component 
of nucleic acids and co-enzymes (Leeson and Summers, 2001). Bone formation is indirectly 




responsible for bone resorption) activity from osteoblasts (bone-forming cells) stimulation 
(Standford, 2006). In individuals with adequate physiological functions, bone resorption and 
formation are tightly balanced (Norman and Hurwitz, 1993) in a process called bone remodeling. 
Hence, bone formation is also stimulated by active release and deposition of Ca and P in the 
mineral matrix of the bone. Additionally, the expression of the calbindin-D28K-mRNA gene in 
the intestinal wall is stimulated by 1, 25(OH)2-D3 (Hall and Norman, 1990). This gene is related 
to the synthesis of calcium binding protein calbindin-D28K. The presence of calbindin-D28K 
reflects the ability of the intestine to absorb Ca efficiently (Combs, 2012). Other functions 
associated with D3 include: regulation of intestinal absorption of P, resorption of P in the renal 
tubes of the kidney (Norman, 1979; Combs, 2012), and immune cell function (Aslam et al., 
1998; Cantorna 2006; Wintergerst et al., 2007).  
 Vitamin D3 deficiency is associated with rickets, tibial dyschondroplasia, retarded 
growth, poor feathering, osteomalacia (bone softening) in adult animals, and pliable beaks and 
claws (Leeson and Summers, 2001). On the other hand, toxicity caused by excessive intake of D3 
is associated with hypercalcemia (McDowell 1989), twisted leg, increased feed conversion ratios 
(FCR) (Cruickshank and Sim, 1987), abnormal deposition of calcium in the viscera due to 
increased circulating calcium and phosphorus levels, and renal damage (Leeson and Summers, 
2001).  
Vitamin D3 Requirement for Growing Meat-type Chickens 
 Literature referenced in the Poultry NRC (1994) used to establish the D3 requirement of 
young growing chickens date as early as 1963 (Table 1). Along with the development of 
specialized meat-type chickens in the late 19
th
 century, breeding programs have focused on 




 Intensive genetic selection has led to an accelerated increase in growth rate of broiler 
chickens (Havenstein et al., 2003). According to data from the National Chicken Council (2017) 
in 1925, it was required a grow-out period of 112-d to produce a broiler chicken with average 




Table 1 Referenced literature in the NRC (1994) to establish vitamin D requirements of 
growing broiler chickens. 
Dietary level 
IU D3/kg 
Duration of study Response criteria Reference 
200-396 28 d 
Performance 
Tibia ash 
Waldroup et al., 1963 
198 28 d 
Performance 
Tibia ash 
Waldroup et al., 1965 
200 54 d 
Performance 
Tibia ash 
Biely and March, 1967 
≤200 14 d 
Performance 
Bone mineralization 
McAuliffe et al., 1976 
198 21 d 
Performance 
Tibia ash 
McNaughton et al., 1977 
400 56 d 
Performance 
Tibia ash 
Lofton and Soares, 1986 




 In contrast, only 47-d are required to produce a broiler chicken with average market 
weight of 2.8 kg (6.2 lb) and FCR of 1.85 in 2017. Along with the intensive genetic selection, 
improvements in flock management, feed technology, vaccination programs, transportation 




poultry strains. As previously mentioned, it is possible that the physiology of modern poultry 
strains has been altered due to the intensive genetic selection and therefore, their ability to 
respond to dietary nutrients (Havenstein et al., 2003; Schmidt et al., 2009; Applegate and Angel, 
2014). Consequently, it is logical to believe that nutrient requirements of modern poultry have 
changed since the last revision of the NRC in 1994 which established the D3 requirement at 200 
IU/kg of diet for starting growing broiler chicks. However, current industry-type poultry diets are 
supplemented with 10 or even 30 times the NRC (1994) recommendations (Leeson, 2007). 
Vitamin requirements found in the NRC (1994) were estimated based on simple observational 
response criteria such as the absence of classical deficiency signs or growth performance 
variables (Leeson, 2006; 2007). The development of new technologies allows researchers to test 
more extensive or diverse response criteria such as blood chemistry, immune responses, or meat 
quality. The use of new technologies to evaluate modern broiler response to dietary nutrients 
suggest different requirements are needed to maximize growth and health (Applegate and Angel, 
2014) when compared to the latest Poultry NRC (1994). Tibia dyschondroplasia scores, 
incidence of rickets, tibial breaking strength, serum P and Ca concentration, cell mediated and 
humoral immune response and mineral retention content of the liver have been employed in 
addition to performance evaluations to estimate dietary D3 requirements for meat-type chickens 
in recent literature reports (Table 2).  
 High dietary concentrations of vitamin D3 [10-20 times NRC (1994) recommendations] 
have been found to positively influence bird’s performance, bone mineralization (Rama Rao et 
al., 2006), and immunity (Aslam et al., 1998), as well as enhance overall welfare by improving 




hock and keel with the litter, thus reducing the development of footpad and hock dermatitis (Sun 
et al., 2013).  
 Increasing concerns among nutritionists regarding the need for re-evaluating nutrient 
requirements that are based on current feeding strategies have increased over the last few years 
(Applegate and Angel, 2014). Hence, it is necessary to adapt and develop strategies that allow 
nutritionist to precisely estimate nutrient requirements of modern poultry strains. Moreover, 
differences in growth between modern poultry strains (Figure 1) should be addressed as well. 
Different D3 requirements to maximize bone mineralization, performance or immunity are 





Figure 1 Growth of Cobb-500 and Cobb-700 modern broiler strains 




















Table 2 Literature reports published after the NRC (1994) estimating vitamin D 
requirements of starting growing broilers. 
Form and 
dietary D3 level 
Strain and 
sex 
















400 IU/kg of feed were needed to 
maximize weight, feed intake, bone 
density, bone calcium and 
phosphorus/cm
3
 bone in a 21 d trial 















200 IU/kg appeared to be sufficient 
to maximize performance and bone 
ash in diets with adequate levels of 
non-phytate P (8-20 d post hatch) 
non-phytate P deficient diets, can 
increase the requirement to 1,500 
IU/kg.Toxicity signs were not 
observed at 50,000 IU/kg 
Baker et al., 1998 
Cholecalciferol 









Incidence of rickets 
Blood chemistry 
 
D3 requirement ranged from 804-
1,131 IU/kg. Estimated requirement 
appeared to be related with D3 
source type and properties of feed 
ingredients. 












Incidence of tibia dyschondroplasia 
 
Approximately 2,000 IU/kg were 
required to maximize tibia ash in 21 
and 42 d old broilers. 








Table 2 Continued 
Form and 
dietary D3 level 
Strain and 
sex 













Tibia ash and breaking strength 
Blood chemistry 
Incidence of tibia dyschondroplasia 
 
The D3 requirement up to 14 d of 
age at sufficient dietary Ca and non-
phytate P may be in the range of 
1,400-2,000 IU/kg based on cortical 
bone quality and 10,000 IU/kg 
required for prevention of tibial 
dyschondroplasia 












Performance and bone 
mineralization in broilers could be 
maintained with suboptimal 
concentration of Ca (0.5%) and non-
phytate P (0.25%) with dietary 
concentrations of D3 above the 1994 
NRC (3,600 IU/kg) 







rice, corn gluten, 




Performance, bone mineralization 
and lymphoid organ weight/body 
weight ratio was significantly 
improved with dietary levels of D3 
at ranging from 1,500-3,500 IU/kg 
in broiler diets 
Khan et al., 2010 
Cholecalciferol 












464 IU/kg of feed to maximize tibia 
ash in a 21 d trial 






The Use of Vitamin D3 Metabolites in Poultry Nutrition  
 Currently, D3 metabolites such as 1-α-hydroxycholecalciferol (1α(OH)D3) and 25-OH-D3 
are commercially available as dietary supplements.  The use of these metabolites in substitution 
or in combination with conventional D3 in poultry diets has become more popular among the 
commercial poultry industry because beneficial effects have been reported in the literature, 
especially as an effective strategy for the prevention of tibial dyschondroplasia in poultry 
(Whitehead, 1995; Ledwaba and Roberson, 2003; Atencio et al., 2005). Edwards et al. (2002) 
investigated the efficacy of 1α(OH)D3 as a substitute for D3. They reported that 1α(OH)D3 was 
approximately eight times as effective as D3 in maximizing body weight, plasma calcium, 
rickets, and percent bone ash in young broiler chickens. Bar et al. (2003) reported that dietary 
25-OH-D3 was beneficial to overcome moderate P restriction on weight gain and bone 
mineralization although, no consistent positive effects were observed in overall performance 
when 25-OH-D3 replaced D3 in broiler diets. Chou et al. (2009) reported improved intestinal 
morphology and enhanced humoral immunity of broiler chickens supplemented with 25-OH-D3 
although no effects were observed in performance variables. Garcia et al. (2013) compared the 
biological activity of 25-OH-D3, 1,25(OH)2 D3 and 1α(OH)D3 to conventional D3 on male 
broiler chickens. Their results suggested that 25-OH-D3 and 1,25(OH)2 D3 were the most 
effective metabolites in maintaining performance and bone quality when compared to 1α(OH)D3.  
Vignale et al. (2015) compared the activity of 25-OH-D3 (5,520 IU/kg) to reduced (2,760 IU/kg) 
and high (5,520 IU/kg) D3 supplementation in male broiler chickens raised up to 42 d of age. The 
supplementation of broiler diets with 25-OH-D3 resulted in increased circulating 25-OH-D3 and 
breast meat yield. Additionally, they reported that muscle of chickens under 25-OH-D3 




groups. Morris et al. (2014) observed that the dietary supplementation of 25-OH-D3 to broiler 
diets improved growth performance and decreased inflammatory gene IL-1β mRNA amounts in 
the liver following a lipopolysaccharide (LPS) injection. In a different study, Morris et al. (2015) 
reported that “high” dietary 25-OH-D3 supplementation (100 µg/kg) to layer chick diets was 
effective in reducing the negative performance effects after coccidia challenge. Additionally, 
dietary 25-OH-D3 decreased IL-1β mRNA and increased IL-10 mRNA amounts in the cecal 
tonsils, suggesting that the D3 metabolite was effective in modulating immune response after 
coccidia challenge.  
 Precautions should be taken when using D3 metabolites as they might increase the risk of 
D3 toxicity in poultry. Yarger et al. (1995) conducted two experiments using graded dietary 
levels of 25-OH-D3 in broiler diets. In the first experiment, dietary 25-OH-D3 was supplemented 
from 69 (basal level) to 690 µg/kg. No toxic effects were observed with increasing 25-OH-D3 
levels in broiler diets. In the second experiment, dietary 25-OH-D3 was supplemented from 69 
(basal level) to 13,800 µg/kg. At 10 times the basal 25-OH-D3 dietary level, evidence of renal 
calcification in birds was observed; whereas, dietary levels of D3 at 50 times the basal level were 
required to show some evidence of renal calcification. The authors concluded that 25-OH-D3 is 5 
to 10 times more toxic than vitamin D3. 
Vitamin D3 Beyond Bone Mineralization 
 Performance, bone mineralization, and incidence of tibial dyschondroplasia have been 
historically used to assess the effects of dietary D3 on poultry. However, there are literature 
reports suggesting vitamin D3 plays an important role in poultry immunity (Aslam et al., 1998; 
Gómez-Verduzco et al., 2013; Morris et al., 2014; Morris et al., 2015), and therefore, the 




 The vitamin D receptor (VDR) belongs to the nuclear receptor superfamily and has been 
detected in many cells types (Wang and DeLuca, 2012). The VDR regulates the expression of 
several genes whose promoters contain vitamin D response elements (Norman and Powell, 
2014), and it is thought that D3 participates in the regulation of normal function in cells 
expressing the VDR. Although the role of D3 in immunity regulation is still not well understood, 
researchers have been exploring this area in recent years as VDR has been found in T 
lymphocyte and macrophage populations (Veldman et al., 2000; Deluca and Cantorna, 2001; 
Wang and DeLuca, 2012). Suggested regulatory points of vitamin D in immune function include: 
1) regulation of T-cell mediated immunity; 2) stimulation of growth factor TGFβ-1 and IL-4 
(Deluca and Cantorna, 2001); 3) inhibition of IL-2 transcription; 4) reduced expression of 
chemokine receptors CXCR3 and CCR2 (Lucas et al., 2014).  
 Evidence of beneficial effects of dietary D3 in mammalian immunity has been reported in 
the literature. Wintergerst et al. (2007) reported that a deficiency in vitamin D can increase 
susceptibility to infections due to impaired localized innate immunity and defects in antigen-
specific cellular immune response in humans. Barrera et al. (2015) studied the relation between 
vitamin D and cytokine expression in the human placenta of healthy and preeclamptic 
pregnancies. They observed that vitamin D supplementation downregulated the expression of 
pro-inflammatory cytokines TNF-α, IL-6 and IFN-γ in preeclamptic women. Additionally, 
vitamin D inhibited mRNA expression and protein levels of IL-10 in cultures obtained from 
normotensive pregnant women. Cantorna (2006) studied autoimmune disorders in mice and 
found evidence of vitamin D having a positive effect in the regulation of T-cell development and 
function, which should decrease the susceptibility of autoimmune diseases such as, multiple 




 In the particular case of birds and more specifically poultry species, Aslam et al. (1998) 
found that a broiler starter diet devoid of D3 depresses the cellular immune response in young 
chicks by reducing the relative weight of the thymus and the number of abdominal macrophages. 
Huff et al. (2000) reported vitamin D3 having a positive effect on performance, mortality, 
relative weight of liver and heart, and serum levels of glucose and alanine aminotransferase 
(ALT) of turkeys subjected to dexamethasone (DEX) challenge. They concluded that dietary D3 
provided a protective effect to the DEX challenge and has a direct effect on health and disease 
resistance of turkeys. Morris et al. (2014) observed that the dietary supplementation of 25-OH-
D3 to broiler diets improved performance and decreased inflammatory gene IL-1β mRNA 
amounts in the liver after lipopolysaccharide (LPS) injection. Morris and Selvaraj (2014) studied 
in vitro supplementation of 25-OH-D3 on chicken monocytes and a HD11 macrophage cell line 
subjected to LPS challenge. They found that 25-OH-D3 treatment increased the production of 
nitric oxide (NO) and mRNA expression of IL-1β, IL-10, 1α-hydroxylase and 24-hydroxylase in 
HD11 cells following LPS stimulation. Morris et al. (2015) reported that 25-OH-D3 influenced in 
vitro expression of IL-10 mRNA using HD11 chicken macrophage cell lines. Additionally, 
Morris and colleagues in the same study used layer-type chicks that were orally challenged with 
1×10
5
 live coccidia oocysts at 21 d of age and supplemented with 6.25, 25, 50 or 100 μg of 25-
OH-D3 per kg of feed. Their results revealed evidence suggesting that the D3 metabolite has a 
regulatory effect on body weight, CD8+ cells, IL-10 mRNA expression and CD4+CD25+ cells. 
Moreover, dietary 25-OH-D3 supplementation (100µg/kg) decreased IL-1β mRNA and increased 
IL-10 mRNA amounts in the cecal tonsils. Shojadoost et al. (2015) studied the effect of D3 on 
chicken macrophage activity using a MQ-NCSU cell line, which is derived from chicken 




concentrations ranging from 0.1 to 0.001 pM and were subjected to different stimuli. They 
observed chicken macrophages expressed VDR and the expression was upregulated when 
exposed to LPS stimulation. Additionally, 1,25(OH)2 D3-treated cells increased the ability of 
macrophages to respond to stimuli and produce NO, but D3 alone did not activate macrophages 
and resulted in downregulation of CD86, MHC-II, CXCL8, and IL-1β. The authors concluded 
that vitamin D3 may have an anti-inflammatory and immunomodulatory role in chickens similar 
to what is seen in mammals. Further research has to be done in this area to better understand the 
relationship between vitamin D3 and immunity using different diet formulations, D3 metabolites 
and the prescience of pathogens such as coccidia which is commonly found in industry-type 
facilities raising poultry under intensive conditions.  
Coccidiosis in Chickens 
 According to the Merck Veterinary Manual (MVM), coccidiosis is defined as “an acute 
invasion and destruction of intestinal mucosa by protozoa of the genera Eimeria or Isospora”. 
Coccidiosis is one of the most economically important diseases affecting the commercial poultry 
industry. Just for the broiler industry, around $3 billion USD are spent worldwide every year in 
the prevention of coccidiosis (Anon., 2013). Clinical signs and lesions include intestinal 
hemorrhages and inflammation, bloody feces, reduced performance, listlessness, pale combs and 
wattles, ruffled feathers, diarrhea, and dehydration (MVM, 2010). Eimeria species recognized to 
infect chickens are: E. acervulina, E. brunetti, E. maxima, E. mitis, E. necatrix, E. praecox, and 
E. tenella (De Gussem, 2007). On the other hand, E. meleagrimitis, E. adenoeides, and E. 
gallopavonis are the most common Eimeria species affecting the turkey (Chapman, 2008).  
 Eimeria species are host specific parasites (Yun et al., 2000); this means that very rarely 




duck. Additionally, intestinal lesions caused during coccidia infections have a particular location 
and appearance facilitating the diagnosis and treatment (Table 3). Eimeria is spread by the fecal-
oral route and its life cycle is complex (Figure 2). Briefly, unsporulated oocysts excreted through 
the feces get in contact with the litter. In the presence of moisture, oxygen and warmth oocysts 
will sporulate and become infective. Sporulated oocysts are ingested by the bird and reach the 
gizzard where they get crushed and sporocysts are released. Sporocysts undergo excystment in 
the duodenum and sporozoites are released to invade the intestine. Sporozoites undergo two 
cycles of asexual reproduction and one cycle of sexual reproduction to form newly unsporulated 





Figure 2 Eimeria life cycle 




Table 3 Eimeria spp. affecting the chicken. 
Species Lesions and diagnosis 
Eimeria 
tenella 
Localized only in the ceca. Infection cause severe morbidity, mortality and 
reduced weight gain. Lesions include: severe inflammation of the ceca, 
accumulation of blood in the ceca, and bloody droppings. 
Eimeria 
necatrix 
Infects the anterior and middle portion of the small intestine. Infection results in 
high mortality. Lesions include small white spots, observed on the serosal 
surface of the intestine. Severe enteritis with thickening, congestion (blood, 
mucus, and fluid), hemorrhage, and necrosis along with bloody feces. 
Eimeria 
acervulina 
Moderately severe pathogen usually affecting the anterior 1/3 portion of the 
small intestine. Lesions include mild to severe enteritis, numerous whitish, oval 
or transverse patches in the upper half of the small intestine and thickening of the 
mucosa. Clinically protracted disease of chicken and results in poor growth, 
increase in culls and increased mortality. 
Eimeria 
maxima 
Moderate pathogen which has a significant effect on weight gain and feed 
conversion. Develops in the middle section of the small intestine, where it causes 
dilatation and thickening of the wall, petechial hemorrhage and a reddish, 
orange, or pink viscous mucous exudate and fluid 
Eimeria 
brunetti 
Affects the lower small intestine, colon, ceca, and cloaca. Moderately severe 
pathogen causing debris covering intestinal mucosa and cheesy cores. 




 The severity of coccidia infections is influenced by many factors, such as host age, 
genetic background and concurrent infections as well as coccidial species (Vermeulen et al., 
2001). Eimeria necatrix and Eimeria tenella are the most pathogenic in domestic chickens 
(MVM, 2010).  
Development and Applications of Anticoccidial Vaccines 
 Anticoccidial medications and vaccines are used to prevent and control coccidiosis in 
commercial poultry facilities (De Gussem, 2007). The use of live oocyst vaccines in young birds 
has the advantage of inducing early coccidia cycling, which results in early development of 




multiple Eimeria species to infect the birds with a low number of parasites that will induce 
protective immunity after two or three consecutive re-infections (Sharman et al., 2010).  Four 
main types of vaccines (live virulent vaccine, live attenuated vaccine, live-tolerant to ionophores 
vaccine and recombinant vaccine) have been developed as a means to prevent coccidial 
infections (Vermeulen et al., 2001; Sharman et al., 2010). The use of live pathogens is associated 
with reduced performance due to the induced subclinical infection. Therefore, the attenuation 
techniques to reduce the pathogenicity of coccidial parasites have received special attention 
(Lillehoj and Trout, 1993). Live virulent vaccines are developed from laboratory or field strains 
without any modification that alters their natural virulence (Ahmad et al., 2016). Examples of 
live vaccines for coccidiosis control include Advent™, Coccivac-B52™ and Immucox™. The 
efficacy of live vaccines relies on the use of live parasites to induce immunity through repeated 
exposure to oocysts in the litter (Sharman et al., 2010). This process is called “recycling” and is 
critical for the development of immunity. Live virulent vaccines are more commonly used in 
breeder flocks rather than in broiler production (Lillehoj and Trout, 1993). The reason is that live 
vaccines present two major disadvantages: 1) immunovariant infection within a flock can lead to 
the emergence of new strains (Ahmad et al., 2016) and 2) potential excessive accumulation of 
oocysts in the litter may lead to disease outbreaks (Lillehoj and Trout, 1993).  
 Live attenuated vaccines such as Paracox-5™, Livacox-T™, and Eimerivax 3m™, are 
developed from parasites with artificially reduced virulence (Vermeulen et al., 2001), usually 
achieved by serial in vivo passage of parasites through embryonated eggs, by selection for 
precocity of oocysts (Dalloul and Lillehoj, 2005), or by parasite irradiation (Lillehoj and 
Lillehoj, 2000).  A major advantage of live attenuated vaccines over live virulent vaccines is the 




lining (Vermeulen et al., 2001; Ahmad et al., 2016) and reduced mortality (Lillehoj and Lillehoj, 
2000).  
 Live-tolerant to ionophores vaccines are developed from Eimeria strains tolerant to anti-
coccidial drugs (Vermeulen et al., 2001). The objective of co-administering ionophore drugs and 
live vaccines at the same time (Ahmad et al., 2016) is to promote immune protection during the 
first 3-4 weeks of life (Kitandu and Juranova, 2006). However, these vaccines have the same 
disadvantages related to the use of live vaccines which include potential capacity of oocysts to 
revert to a more pathogenic state. Additionally, increased risk in ionophore resistance is also a 
problem (Ahmad et al., 2016). Examples of live-tolerant to ionophore vaccines include Nobilis-
Cox ATM™ and Vac M™. 
 Recombinant vaccines are developed through recombinant DNA technology. 
Recombinant vaccines have received special attention as an alternative for the problems 
associated with live vaccines (Lillehoj and Trout, 1993). Protein recombinant vaccines are 
derived from purified pathogen proteins or subunits (Nascimiento and Leite, 2012). Sporozoites 
are the preferred parasitic form used for the development of recombinant protein vaccines due to 
their availability and effectiveness in preventing infection (Lillehoj and Lillehoj, 2000). 
Recombinant protein vaccines depend on DNA encoding an antigen that stimulates an immune 
response, then expressing the antigen in cells for the final purification process. Recombinant 
DNA vaccines employ genes encoding immunogenic proteins of pathogens rather than the 
proteins themselves (Lillehoj and Lillehoj, 2000) as in protein recombinant vaccine 
development. 
 Current delivery strategies of anticoccidial vaccines consist on oocysts suspensions that 




ingest the oocysts by preening themselves and each other (Dalloul and Lillehoj, 2005). Other 
routes of administration include ocular drops, water suspensions, and in ovo injection (Ahmad et 
al., 2016).   
Selected Cytokine Secretion During Coccidiosis Infection in Chickens  
 Cytokines are proteins that coordinate and regulate the activity of innate and adaptive 
immunity (Abbas et al., 2014). Chickens that have been vaccinated or naturally infected by 
Eimeria parasites produce specific immunity responses mediated by T cells and B cells (Hong et 
al., 2006). These responses include the secretion of various cytokines. The possible role of 
secreted cytokines during coccidial infection has been an active field of research. For the purpose 
of this literature review the possible roles of IFN-γ, IL-1β, IL-6 and IL-10 (Table 4) during 
coccidial infections will be covered.  
 Interferon-gamma (IFN- γ) secretion has been associated to Eimeria infection in mice and 
chickens (Lillehoj and Trout, 1996). Upregulation of IFN-γ mRNA expression has been observed 
after Eimeria acervulina infection in the cecal tonsils and spleen (Lillehoj et al., 2004). 
Following Eimeria tenella infection IFN-γ transcripts were detected in spleen, cecal tonsils and 
intraepithelial lymphocytes (Lillehoj et al., 2004). Lymphocytes from Eimeria-infected chickens 
were reported to increase the production of IFN-γ when induced with concanavalin A compared 
to lymphocytes from non-infected chickens (Lillehoj and Trout, 1996). Lillehoj et al. (2005) 
studied the effect of in ovo DNA immunization with cloned 3-IE Eimeria gene with or without 
supplemental cytokine genes (IL-1, IL-2, IL-6, IL-8, IL-15, IL-16, IL-17, IL-18, IFN-γ) as 
adjuvants. Their results showed that in ovo vaccination with 3-1E gene in combination with IL-1, 
IL-2, IL-15 and IFN-γ genes induced higher serum antibody responses when compared with 




from eggs vaccinated using 3-1E gene plus IL-15 and IFN-γ when compared to chickens that 
hatched from eggs vaccinated with 3-1E gene alone. The authors concluded that the use of 
cytokine adjuvants such as IFN-γ provide protective intestinal immunity against coccidiosis.  
 Interleukin-1 beta (IL-1β) is associated with inflammatory response, cell differentiation 
and apoptosis regulation in the body (Giraldo et al., 2009). Secretion of IL-1β during coccidial 
infection has been reported in chickens. In vitro production of IL-1β was observed in 
macrophages obtained from Eimeria maxima and Eimeria tenella infected chickens (Byrnes et 
al., 1993). Interleukin-1 beta transcripts were increased 27- to 80-fold 7 d after chickens were 
infected with Eimeria tenella or Eimeria maxima (Laurent et al., 2001). Hong et al. (2006) 
reported that transcripts of pro-inflammatory cytokines (IFN-α, IL-1β, IL-6, and IL-17) were 
increased up to 2,000-fold following Eimeria acervulina and Eimeria tenella primary infection.  
 Interleukin-6 (IL-6) regulates the proliferation of antibody-producing cells (Abbas et al., 
2014). Lillehoj et al. (2004) reviewed the role of IL-6 during the first hours post coccidial 
infection. They reviewed literature reports where bacterially expressed chicken IL-6 was 
biologically active inducing proliferation of the IL-6-dependent murine hybridoma cell line 
7TD1. Additionally, chicken IL-6-like factor activity was detected in chickens infected with E. 
tenella during the course of a primary infection. The authors concluded that IL-6 activity during 
the first hours post-infection indicates a possible role in the development of acquired immunity. 
 Interleukin-10 (IL-10) inhibits the synthesis of proinflamatory cytokines such as, IL-1β 
and IL-6 (Hong et al., 2006). This relationship was observed by Morris et al. (2015) who 
reported that 25-OH-D3 influenced in vitro expression of IL-10 mRNA using chicken 
macrophage cell lines. Additionally, an in vivo study conducted by Morris et al. (2015) using 
layer-type chicks orally challenged with 1×10
5




supplemented with 6.25, 25, or 50 μg of 25-OH-D3 per kg of feed revealed evidence suggesting 
the D3 metabolite has a regulatory effect on body weight, CD8+ cells, IL-10 mRNA expression 
and CD4+CD25+ cells. Moreover, dietary 25-OH-D3 supplementation (100µg/kg) decreased IL-
1β mRNA and increased IL-10 mRNA amounts in the cecal tonsils. It appears that IL-10 has an 




Table 4 Selected cytokine role in general immunity 
Cytokine Cell Source Principal cellular targets and role in immunity 
IFN-γ 
T cells (TH1, CD8
+
 
T cells), NK cells 
Macrophages: classical activation (increased microbial 
functions) 
B cells: isotype switching to opsonizing and IgG subclasses 
T cells: TH1 proliferation 
Various cells: increased expression of class I and class II MHC 









Endothelial cells: activation ( inflammation, coagulation) 
Hypothalamus: fever 
Liver: synthesis of acute-phase proteins 
T cells: TH17 differentiation 
IL- 
Macrophages, 
endothelial cells,  T 
cells 
Liver: synthesis of acute-phase protein 




regulatory T cells) 
Macrophages, dendritic cells: inhibition of expression of IL-12, 
costimulators, and class II MHC 
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CHAPTER II  
DEVELOPING AN ORAL GAVAGE BIOASSAY TO RE-EVALUATE THE VITAMIN 
D3 REQUIREMENT OF GROWING BROILER CHICKENS 
 
INTRODUCTION 
 Cholecalciferol, or vitamin D3 (D3), has been extensively studied due to its potent 
antirachitic activity in poultry and other animal species. It is known that D3 plays an important 
role in calcium (Ca) and phosphorus (P) homeostasis in conjunction with calcitonin and 
parathyroid hormones (Collins and Norman, 2001). Although D3 can be synthesized in the skin 
after exposure to UV-light from the sun, current industry facilities used to raise poultry species 
have limited access to sun light. Therefore, to avoid D3 deficiencies and prevent the incidence of 
bone problems such as, rickets or tibia dyschondroplasia, D3 supplements are widely used in 
poultry vitamin premixes and feed formulations.  
 The Poultry NRC (1994) established the vitamin D3 requirement at 200 IU D3/kg of diet 
for starter growing broiler chicks. However, post NRC (1994) research suggests higher amounts 
of D3 are required for optimal performance (Kasim and Edwards, 2000; Fritts and Waldroup, 
2003; Whitehead et al., 2004; Rama Rao et al., 2006; Khan et al., 2010). Modern commercial 
poultry diets often include up to 20 times the minimal requirement of 200 IU D3/kg specified in 
the NRC (1994). Therefore, it is possible that nutrient requirements of meat type chickens have 
changed since the last revision of the NRC in 1994 which referenced literature, regarding D3 
requirements, dated as early as 1963. Thus, concern among nutritionists regarding the need to re-
evaluate nutrient requirements that are based on the current ability of modern poultry strains to 




 Previous research done in our laboratory investigating relative bioavailability of D3 
sources, have found considerable variability in response to dietary D3. Our biggest challenge is to 
observe a decrease in performance or bone mineralization as indicators of D3 biological activity 
in young growing broilers subjected to D3-deficient diets. Maternal D3, found in the yolk, 
appears to play a key role in the early performance of young broilers and therefore, in their 
response to supplemental D3 as suggested by previous literature reports (Moran, 2007; Coto et 
al., 2010a; Coto et al., 2010b; Saunders-Blades and Korver, 2014). 
 Nutrient requirements have traditionally been determined by adding graded 
concentrations of the nutrient in question to a deficient diet and using broken-line regression to 
assess the response variables. Feed mixing error, selective feeding, and other sources of error 
including chemical nutrient analysis of the test diets are inherently problematic with this 
approach. Thus, the present study focused on reducing the effect of maternal D3 and increasing 
the precision of D3 delivery method to the chickens through a precise gavage intake bioassay. 
Additionally, this study was useful to identify any possible pitfalls in the protocol that will 
possibly be corrected in a second trial. Hence, the results of the first approach to the development 
of the precision gavage intake bioassay will be presented in the following sections of this 
dissertation. 
 
MATERIALS AND METHODS 
 All procedures in this experiment were approved by the Institutional Animal Care and 






Birds and General Management 
 A total of 300 Cobb-500 newly-hatched male broiler chickens were purchased from a 
commercial hatchery. At the time of arrival to the experimental facilities, the birds were weighed 
in groups of 20 and an average body weight (BW) was calculated. The average BW was used to 
create 48 groups of five chickens (n=240) with close to “identical” starting body weight and 
variance. Broilers were then allocated to two stainless steel battery brooders (5 birds per cage) 
inside an environmentally controlled rearing room using a completely randomized block design. 
Battery pen level (6 levels) was used as the blocking factor. Fluorescent 48-inch tube lamps 
covered with red plastic shields were used to provide 24-h constant light. The complete absence 
of UV-light inside the rearing rooms has been previously verified (Fowler et al., 2014) by the 
Texas A&M Environmental Health and Safety Office using a short wave UV meter (J-225 Blak-
Ray, UVP, LLC. Upland, CA). A basal D3-deficient corn-soy broiler starter diet was fed ad 
libitum throughout a 21 d trial period. The first nine days of the study served to deplete the 
maternal stores of D3 followed by a 12-h fasting period. From d 10 to the end of the trial, birds 
were orally gavaged with increasing levels of vitamin D3. Oral D3 treatments were offered for 11 
d. Water was offered ad libitum using nipple drinkers. Birds were monitored daily with regard to 
general flock condition, temperature, lighting, water, feed, and any unanticipated events inside 
the rearing facility.  
Dietary Treatments 
 A basal mash corn-soy broiler starter diet devoid of D3 was formulated using a 
customized vitamin / mineral premix containing no D3 and corn oil as the fat source (Table 5). 
To increase the sensitivity of our response variables to the experimental treatments, the basal diet 




(NPP; 0.37%). Feed intake (FI) reference data for meat-type chickens (Cobb-500 Broiler 
Performance and Nutrition Supplement, 2015) was used to estimate the increasing levels of 
vitamin D3 per kg of feed consumed. Daily oral gavage treatments were based on estimated 
intake of 0, 50, 100, 200, 400, 800, 1,600 and 3,200 IU D3/kg of feed consumed over the last 12 
days of the study (estimated to be 900 g per bird). To create the experimental treatments, a total 
of 30 mg of crystalline vitamin D3 concentrate (cholecalciferol, Ref: 1131009, Sigma-Aldrich, 
St. Louis, MO) were diluted in 100 mL of corn oil (expected to yield 12,000 IU/mL). An aliquot 
of 26.2 mL was diluted again in corn oil (573.8 mL) to yield a concentration of 524 IU D3/mL 
corresponding to the highest treatment dose (≈3,200 IU/kg of feed) and then serial dilutions were 
performed to create the other treatments so that a daily constant dose was contained in 0.5 mL. 
The D3 solutions were separated in 11 daily doses (n=77) and then stored in a freezer at -20°C 
until required. Birds in the control group (0 IU) received 0.5 mL of corn oil without D3 for 11 
days. The oral gavage was performed per treatment group from lower to higher IU concentration 
using an 18-gauge stainless steel gavage needle and a 1 mL syringe graduated at 1/100 mL. The 
gavage needle was flushed with plain corn oil between treatments to avoid cross-contamination. 
The gavage procedure was performed by a single operator who gained proficiency in the delivery 
of a specific oil volume after repeated training (CV x̅ =0.94%). 
Chemical Analysis 
 The stock solution obtained from the dilution of 30 mg of the Sigma D3 standard in 100 
mL of corn oil (calculated to yield 12,000 IU/mL) was sent to a third party commercial 
laboratory for D3 concentration analysis (AOAC-2002.05) to ensure a minimum concentration of 






 Feed intake and BW per pen were recorded on d 10, after the fasting period, and d 21 of 
the trial to calculate weight gain (WG) and feed efficiency (FE). The BW of dead birds was 
recorded daily and used to adjust FE. Feed intake data collected from d 10 to 21 were used to 
adjust the IU of D3 administered through the oral gavage and expressed as IU of D3 per kg of 
feed using the following equations: 
1) TOGIU = S [IU/mL] * 0.5* d 
Where: TOGIU = Total orally gavaged IU’s 
 S = Solution (Corn oil + D3) concentration (Obtained from serial dilutions) 
 d = number of days chickens were orally gavaged 
2) AIUI= (1,000 * TOGIU) / FI 
Where: AIUI = Adjusted IU intake (IU D3/kg of feed) 
  FI = Feed intake (g / bird) 
 
Bone Mineralization 
 On d 21 of the experiment, all birds per pen were euthanized using CO2. Total bone 
mineral content (BMC) and bone mineral density (BMD) were obtained per pen using a Dual X-
ray absorptiometry (DXA) scan (GE Lunar Prodigy Advance, GE-Healthcare, Boston, MA) 
located at the Applied Exercise Science Laboratory of Texas A&M University. Bone mineral 
content is defined as the total bone mineral found in a specific area measured in grams. Bone 
mineral density is derived using BMC (g) divided by an area (cm
2
) of interest. Chickens were 





Table 5 Basal vitamin D3 deficient broiler starter diet 
Ingredient   Basal Diet 
1
 (%) 
Yellow corn 62.7 
Dehulled soybean meal  32.1 
DL-Methionine 0.15 
L-Lysine-HCl 0.34 
Corn oil 1.81 
Limestone 1.06 
Monocalcium phosphate 1.19 
Sodium chloride (salt) 0.46 




Calculated nutritional content was as follow: 22% crude protein, 3050 kcal/kg metabolizable energy, 0.75% 
calcium, 0.37% non-phytate phosphorous, 0.48% methionine, 0.85% methionine+cystine, 1.2% lysine, 0.26% 




Vitamin-mineral premix added at this rate yields per kg of diet: 10 mg copper, 2 mg iodine, 20 mg iron, 125 mg 
manganese, 125 mg zinc, 0.2 mg selenium, 8,000 IU vitamin A, 40 IU vitamin E, 2 mg menadione, 4 mg thiamine, 8 
mg riboflavin, 60 mg niacin, 15 mg pantothenic acid, 4 mg pyridoxine, 0.18 mg biotin, 2 mg folic acid, 0.02 mg 




 Data were analyzed using the small animal software (GE Lunar Prodigy Advanced 
enCore, V 16.0, GE-Healthcare, Boston, MA). After the DXA scan both tibiae were removed, 
labeled and stored in a freezer (-20°C) until further analysis. The right tibiae were gently boiled 
for 2-h in water and defatted in petroleum ether for 48-h. Defatted bones were then dried in a 
forced draft oven (95°C) until a constant weight was registered (≈48 h). Finally, the dried bones 
were ashed at 650°C for 23-h. Percent tibia bone ash (TBA) was calculated based on starting dry 
bone weight and remaining ash expressed as percent. The left tibiae were cleaned from any 
adhering tissue and used to assay breaking strength (TBS) using a texture analyzer (TA.XT Plus, 
Texture Technologies, Hamilton, MA,) charged with a 50-kg load cell, a crosshead speed of 100 






 Collected data were analyzed as one way-ANOVA where treatment and block were used 
as fixed factors in the model. Battery level was used as the blocking factor. Means were 
separated by Duncan’s multiple range test when appropriate. Linear and quadratic effects of 
graded levels of D3 were investigated by regression analysis. The 0 IU group was included as 
common control to investigate linear and quadratic effects. Three different regression models 
were used to calculate the D3 requirement. The one-slope straight broken-line regression model 
consists of a line with an increasing or decreasing slope and a horizontal line. The intersection 
between the two lines is the breaking point. The one-slope broken-line model is as follows: y = L 
+ U* (R-x), where (R-x) is defined as zero when x > R. The two-slope straight broken-line 
regression model is defined as y = L + U*(R-x) + V*(x-R), where (R-x) is defined as zero when 
x > R, and (x-R) is defined as zero when x < R. In the two-slope model, both intersecting lines 
have non-zero slopes. The derived parameters for both linear models are the breaking point x 
value (R), an asymptote for the first segment (L), and slope for the two line segments (U, V). The 
point of intersection or breaking-point between the two lines was defined as the estimated D3 
requirement. Finally, the quadratic broke-line model is described as y= L + U*(R-x)
2
. The 
concentration at which the response reached 95% of the minimum response was estimated as the 
D3 requirement (Robbins, 1986; Robbins et al., 2006; Jiang et al., 2015). One-way ANOVA 
analysis and linear regression (linear and quadratic effects) were performed by IBM SPSS 
software (SPSS Version 25.0, SPSS Inc., Chicago, IL) and the SAS software (SAS Version 9.4, 
SAS Institute, Cary, NC) was employed for the estimation of the D3 requirement using the 
NLMIXED procedure. The Akaike Information Criterion (AIC; smaller values indicate better 
fit), coefficient of determination (R
2
) and adjusted R
2 




the three models. The pen average was the experimental unit for performance and bone 
mineralization responses. Significant effects were accepted at P<0.05 for all analyses. 
 
RESULTS AND DISCUSSION 
Performance 
 Performance results are presented in table 6. Although BW and WG of chickens orally 
gavaged with graded levels of D3 was numerically improved, no differences (P>0.05) were 
observed between treatment groups. Graded levels of D3 did positively improve (P<0.05) FE. 
However, this improvement was detected between the 0 IU treatment and the other treatment 
groups only. Overall, no linear or quadratic effects (P>0.05) were observed for any of the 
performance responses but WG (P=0.039) which linearly increased with dietary concentrations 
of D3. FI was similar among treatment groups, but was relatively low to the estimated intake of 
900 g used to calculate total IU consumed over the experimental period. Thus, adjusted IU D3/kg 
feed were over the estimated feed intake for all treatment groups.  
 While not very precise, multiple range tests are a simple and easy way to obtain an 
approximation or estimation of a nutritional requirement (Pesti et al., 2009). Observed 
differences between treatment groups will indicate where the response variable was maximized. 
However, this methodology was difficult to implement in the present study due to a lack of 
consistency in the performance response to dietary D3 and that no differences (P>0.05) were 







Table 6 Effect of dietary vitamin D3 on performance of broiler chickens 






21 d 10-21 d 10-21 d 10-21 d 
BW WG FE FI 
0  711±23  504±22 0.69±0.018
b
  725±19 
50 (61)  725±14  527±10 0.72±0.010
a
 736±13 
100 (122)  742±13  536±11 0.73±0.006
a
  738±13 
200 (242)  741±16  544±10 0.73±0.010
a
  746±19 
400 (480)  722±17  530±10   0.71±0.015
ab
  753±21 
800 (961) 740±9 544±9  0.72±0.004
a
  750±10 
1600 (1950)  734±12  534±10  0.72±0.005
a
  740±10 
3200 (3733)  754±16  557±16  0.73±0.007
a
   776±23 
P value     
Linear 0.146 0.039 0.132 0.055 
Quadratic 0.962 0.822 0.534 0.795 
a-b
 Means within the same column without a common superscript differ (P<0.05) Duncan's multiple range test. 
Means ± SEM. 
1
 Calculated IU D3/kg feed (Adjusted IU D3/kg feed based on feed intake data). 
2
 Chemical analysis of stock solution (crystalline vitamin D3 concentrate + corn oil) expected to yield 12,000 IU 
D3/mL) was performed at Cornerstone Laboratories, LLC by AOAC-2002.05 (1775 Moriah Woods Blvd., Ste. 12 
Memphis, TN 38117). Analyzed D3 concentration was 12,800 IU D3/mL. Serial dilutions using the stock solution were 
performed to create dietary D3 treatments so that a daily constant dose was contained in 0.5 mL. D3 was 
administered to the chickens through a daily oral gavage.  
3 
BW, Body weight (g/bird); WG, Weight gain (g/bird); FE, Mortality corrected feed efficiency (g weight gain / g 
feed intake), FI, feed intake (g). 
4
 Values for performance responses represent the mean average of n=6 replicate pens per treatment of 5 birds each at 




 Despite the fact that performance responses are not very sensitive to dietary D3 or mineral 
inadequacy (Waldroup et al., 1963; Edwards et al., 1994; Angel et al., 2005), early performance of 
growing broilers is highly influenced by maternal D3 found in the egg yolk (Moran, 2007; Coto 
et al., 2010a; Coto et al., 2010b; Saunders-Blades and Korver, 2014). Performance results 
obtained in the present study suggest that the depletion period of 9-d prior to the introduction of 
the oral gavage and lowering the Ca and NPP content in the diet were not very effective in 




had high maternal reserves of D3. It is known that commercial poultry diets contain high dietary 
concentration of fat-soluble vitamins. In the U.S.A., vitamin D3 is commonly supplemented at 
3,000-4,000 IU D3/kg feed in broiler breeder diets (Leeson and Summers, 2005). This is 
probably the biggest obstacle to overcome when evaluating vitamin D3 requirements using 
“commercial” broiler chickens. Additionally, the low FI registered could have potentially 
reduced the growth rate of the chickens and consequently, reduced the demand for nutrients, 
which ultimately, decreased even further the sensitivity of the experiment.  
Bone Mineralization 
 The effect of dietary vitamin D3 on bone mineralization is presented in table 7. Tibia 
bone ash and TBS increased linearly (P<0.05) in response to increasing dietary concentrations of 
D3. Moreover, differences (P<0.05) were observed among treatments groups and when compared 
with the 0 IU treatment group. No significant effect of dietary D3 was observed for BMD or 
BMC. However, BMC appeared to have a linear response to dietary increasing concentrations of 
D3. Similar to performance responses, bone mineralization results were not very consistent 
within the treatment groups. However, the multiple range test approach to estimate the D3 
nutritional requirement is possible. Based on Duncan’s multiple range test, it appears that 480-
961 IU D3/kg feed are necessary to maximize TBA and TBS. The main disadvantage of this 
approach is the lack of precision (Pesti et al., 2009) and therefore, other methodologies are 
necessary to have a better estimate of the nutritional requirement but as previously mentioned is 
a good starting point to estimate nutritional requirements.  
 Interestingly, TBA for the 0 IU treatment group averaged 47.2 %. Compared to the other 
treatment levels in average this represents a ≈1.2% decrease in tibia bone ash. Previous 




D3 and increase the sensitivity of the studied responses to dietary D3 accomplished a 5.0% 
decrease in TBA (Leyva-Jimenez et al., 2018) which resulted in a more consistent performance 
and bone mineralization response to graded levels of D3. Similar reductions (4-6%) in tibia ash 
were reported by Khan et al. (2010) and Jiang et al. (2015) using commercial broilers to estimate 
vitamin D3 requirements and overall reported a consistent response to dietary D3. These results 
support the hypothesis that a D3 deficiency was not effectively induced in this experiment and 




















































 0.067±0.005 4.36±0.33 
P value     
Linear <0.001 <0.001 0.246 0.027 
Quadratic 0.873 0.104 0.127 0.319 
a-c
 Means within the same column without a common superscript differ (P<0.05) Duncan's multiple range test. 
Means ± SEM. 
1
 Calculated IU D3/kg feed (Adjusted IU D3/kg feed based on feed intake data). 
2
 Chemical analysis of stock solution (crystalline vitamin D3 concentrate + corn oil) expected to yield 12,000 IU 
D3/mL) was performed at Cornerstone Laboratories, LLC (1775 Moriah Woods Blvd., Ste. 12 Memphis, TN 38117). 
Analyzed D3 concentration was 12,800 IU D3/mL. Serial dilutions using the stock solution were performed to create 
dietary D3 treatments so that a daily constant dose was contained in 0.5 mL. D3 was administered to the chickens 
through a daily oral gavage. 
3
 TBA, tibia bone ash (%); TBS, tibia breaking strength (kg force); BMD, bone mineral density (g/cm
2
); BMC, bone 
mineral content (g). 
4
 Values for bone mineralization responses represent the mean average of n=6 replicate pens per treatment of 5 birds 




Requirement Estimation Using Regression Models 
 To estimate the vitamin D3 requirement with better precision than the multiple range test 
methodology, TBA and TBS response of growing broiler chickens to graded levels of D3 was 
fitted to three different regression models are presented in table 8. Performance variables were 
not reported as criteria to estimate the D3 requirement because the low response to graded levels 
of D3 and also because regression models yielded very low AIC, R
2
 and adjusted R
2
. For TBA 
the one-slope broken model yielded a D3 requirement of 491 IU/kg of feed.  The two-slope 
broken line model resulted in an estimated D3 requirement of 532 IU/kg of feed. The quadratic 
model resulted in an estimated requirement of 497 IU/kg of feed. On the other hand, D3 
requirements needed to maximize TBS were higher when compared to TBA. The one-slope 
broken model yielded a D3 requirement of 574 IU/kg of feed.  The two-slope broken line model 
estimated the D3 requirement at 658 IU/kg of feed. Finally, the quadratic model resulted in an 
estimated requirement of 798 IU/kg of feed. 
 Overall, in this experiment the non-linear quadratic regression models resulted in better 
AIC, R
2
 and adjusted R
2
 than both linear models.  The results of this experiment, suggest that the 
quadratic model was better to explain the response of broiler chickens to dietary D3. In 
agreement with previous literature reports, quadratic models are preferred to explain nutritional 
response data because they provide advantages over linear models. First, they have more 
flexibility and allow fitting a decreasing response usually associated with toxic levels of a 
nutrient (Pesti et al., 2009). Additionally, non-linear models tend to accurately describe the 
saturation response to a nutrient as a smooth curvilinear response rather than an abrupt saturation 
associated with linear models (Curnow, 1973; Coma et al., 1995; Robbins et al., 2006).  In 




broken-line models (Robbins et al., 2006), fitting a quadratic model requires a minimum of 3 
points below the estimated requirement (Robbins et al., 2006) and usually estimate bigger 



















One-slope straight broken line 491 154.90 0.172 0.007 
Two-slope straight broken line 532 156.70 0.175 0.003 
Quadratic broken line 497 153.20 0.201 0.028 
TBS 
One-slope straight broken line 574 175.60 0.315 0.167 
Two-slope straight broken line 658 193.20 0.273 0.116 
Quadratic broken line 798 174.80 0.326 0.180 
1
TBA, tibia bone ash (%); TBS, tibia breaking strength (kg force) 
2
 The one-slope straight broken-line regression model is y = L + U* (R- x), where (R-x) is defined as zero when x > 
R. The two-slope straight broken-line regression model is defined as y = L + U* (R- x) + V *(x-R), where (R − x) is 
defined as zero when x > R, and (x − R) is defined as zero when x < R. The derived parameters for both models are 
the breaking point x value (R), an asymptote for the first segment (L), and slope for the two line segments (U, V).    




 Estimated requirement, ER (IU D3/kg of feed). 
4




 The results of the present experiment are in agreement with post-NRC (1994) literature 
reports suggesting higher dietary D3 levels over the standard 200 IU/kg of feed are required to 
maximize growth and bone mineralization (Kasim and Edwards, 2000; Fritts and Waldroup, 
2003; Whitehead et al., 2004; Rama Rao et al., 2006; Khan et al., 2010). However, we could 
expect an increment in the vitamin D3 requirement due to the reduction of Ca and NPP in the diet 




the NRC (1994) of 200 IU/kg of feed is still adequate for starting growing broilers. In multiple 
research projects conducted by our laboratory team using graded levels of dietary D3, we have 
noticed that the studied variables maximize before or around the 200 IU/kg of feed. For this 
purpose future studies will re-evaluate the D3 requirement of broiler chickens using strain and 
age adequate dietary Ca and NPP. Additionally, growth will be stimulated by increasing feed 
intake as a result of offering the feed as crumbles. Finally, estimated D3 IU intake from d 10 to 
21 will be adjusted to better reflect the expected feed intake (reduced 50 g from 900 g).  
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A RE-EVALUATION OF THE VITAMIN D3 REQUIREMENT FOR GROWING 
BROILER CHICKENS USING AN ORAL VITAMIN D3 INTAKE BIOASSAY 
 
INTRODUCTION 
 Cholecalciferol is a fat-soluble vitamin (D3) typically used in animal nutrition to prevent 
skeletal disorders due to its role in calcium and phosphorus homeostasis. In particular, 
commercial poultry feed formulations require D3 to be included in the diet because endogenous 
synthesis of D3 is very limited. Indoor enclosures used to grow poultry species usually do not 
have access to sunlight and therefore, the birds depend on dietary D3 to have an optimal growth 
and development of their skeleton.  
 The last NRC update on the vitamin D3 requirement for young meat-type chickens was 
established at 200 IU/kg of feed in 1994. Since then, very limited research has been done on the 
estimation of fat-soluble vitamins such as D3 (Leeson, 2007; Światkiewicz et al., 2017). 
Additionally, over the last 24 years, intensive genetic selection, flock management, precise 
nutrition and improvements in vaccine technology have led to the development of very efficient 
fast-growing modern poultry strains. Thus, it is logical to think that the NRC (1994) D3 
requirement might no longer be adequate to promote optimal performance and bone development 
of modern poultry strains. Moreover, post NRC (1994) literature reports (Kasim and Edwards, 
2000; Fritts and Waldroup, 2003; Whitehead et al., 2004; Rama Rao et al., 2006; Khan et al., 
2010) suggest that high concentrations of dietary D3 (up to 20x the 1994 NRC) is necessary for 




 To address this problem, our research team tried to develop a protocol that would 
precisely estimate the vitamin D3 requirement of young growing broilers and would adapt to the 
current ability of meat-type chickens to respond to dietary nutrients. This protocol focused on 
reducing feed mixing error, selective feeding, and other sources of error usually associated with 
typical methodologies of estimating nutrient requirements; as well as reducing the effect of 
maternal D3 found in the egg yolk and increasing the precision of D3 delivery to the chickens. 
The first approach to the protocol was covered in the previous chapter of this dissertation. The 
present study corresponds to a second trial where some adjustments were done to the first 
protocol in an attempt to continue with the development of a precision oral gavage bioassay to 
estimate the D3 requirement of growing broiler chickens.  
 
MATERIALS AND METHODS 
 All procedures in this experiment were approved by the Institutional Animal Care and 
Use Committee of Texas A&M University (AUP: IACUC 2017-0072). 
Birds and General Management 
 A total of 300 Cobb-700 newly-hatched male broiler chickens were purchased from a 
commercial hatchery. At the time of arrival to the experimental facilities, birds were weighed in 
groups of 20 and an average body weight (BW) was calculated. The average BW was used to 
create 48 groups of five chickens (n=240) with close to “identical” starting body weight and 
variance. Broilers were then allocated to two stainless steel battery brooders (5 birds per cage) 
inside an environmentally controlled rearing room using a completely randomized block design. 
Battery pen level (6 levels) was used as the blocking factor. Fluorescent 48-inch tube lamps 




of UV-light inside the rearing rooms has been previously verified (Fowler et al., 2015) by the 
Texas A&M Environmental Health and Safety Office using a short wave UV meter (J-225 Blak-
Ray, UVP, LLC. Upland, CA) to prevent the endogenous synthesis of D3. A basal D3-deficient 
corn-soy broiler starter diet was fed ad libitum throughout a 21 d trial period. The first nine days 
of the study served to deplete the maternal stores of D3 followed by a 12-h fasting period. From d 
10 to the end of the trial, birds were orally gavaged with increasing levels of vitamin D3. Oral D3 
treatments were offered for 11 d. Water was offered ad libitum during the whole trial using 
nipple drinkers. Birds were monitored daily with regard to general flock condition, temperature, 
lighting, water, feed, and any unanticipated events inside the rearing facility. 
Dietary Treatments 
 A basal corn-soy broiler starter diet devoid of D3 was formulated based on the nutrient 
recommendations of Cobb-700. A customized vitamin / mineral premix containing no D3 and 
corn oil were used (Table 1) to formulate the basal D3-deficient diet. The D3-deficient basal diet 
was fed as crumbles throughout the trial period.  
 Feed intake (FI) reference data for meat-type chickens (Cobb-700 Broiler Performance 
and Nutrition Supplement, 2012) was used to estimate the increasing levels of vitamin D3 per kg 
of feed consumed. Daily gavage treatments were based on estimated FI of 0, 50, 100, 200, 400, 
800, 1,600 and 3,200 IU D3/kg of feed consumed over the last 12 days of the study (estimated to 
be 850 g per bird). To create the experimental treatments, a total of 30 mg of the vitamin D3 
concentrate (Cholecalciferol, Ref: 1131009, Sigma-Aldrich, St. Louis, MO) were diluted in 120 
mL of corn oil (expected to yield 10,000 IU/mL). An aliquot of 29.7 mL was diluted again in 
corn oil (570.3 mL) to yield a concentration of 494.6 IU D3/mL corresponding to the highest 




other treatments so that a daily constant dose was contained in 0.5 mL. The D3 solutions were 
separated in 11 daily doses (n=77) and then stored in a freezer at -20°C until required. Birds in 
the control group (0 IU) received 0.5 mL of corn oil without D3 for 11 days. The oral gavage was 
performed per treatment group from lower to higher IU concentration using an 18-gauge gavage 
needle and a 1 mL syringe graduated at 1/100 mL. The gavage needle was flushed with plain 
corn oil between treatments to avoid cross-contamination. The gavage procedure was performed 
by a single operator who gained proficiency in the delivery of a specific oil volume after 
repeated training (CV x̅ =0.94%).  
Performance Evaluation 
 FI and BW per pen were recorded on d-10, after the fasting period, and d-21 of the trial to 
calculate weight gain (WG) and feed efficiency (FE). The BW of dead birds was recorded daily 
and used to adjust FE. FI data collected from d 10 to 21 were used to adjust the IU of D3 
administered through the oral gavage and expressed as IU of D3 per kg of feed using the 
following equations: 
1) TOGIU = S [IU/mL] * 0.5* d 
Where: TOGIU = Total orally gavaged IU’s 
 S = Solution (Corn oil + D3) concentration (Obtained from serial dilutions) 
 d = number of days chickens were orally gavaged 
2) AIUI= (1,000 * TOGIU) / FI 
Where: AIUI = Adjusted IU intake (IU D3/kg of feed) 






Table 9 Basal broiler starter diet devoid of vitamin D3 
Ingredient   Basal Diet 
1
 (%) 
Yellow corn 62.1 




Corn oil 1.99 
Limestone 1.31 
Monocalcium phosphate 1.55 
Sodium chloride (salt) 0.16 
Sodium bicarbonate 0.27 




Calculated nutritional content was as follow: 22% crude protein, 3050 kcal/kg metabolizable energy, 0.90% 
calcium, 0.45% non-phytate phosphorous, 0.65% methionine, 1.0% methionine+cystine, 1.36% lysine, 0.26% 




Vitamin-mineral premix added at this rate yields per kg of diet: 10 mg copper, 2 mg iodine, 20 mg iron, 125 mg 
manganese, 125 mg zinc, 0.2 mg selenium, 8,000 IU vitamin A, 40 IU vitamin E, 2 mg menadione, 4 mg thiamine, 8 
mg riboflavin, 60 mg niacin, 15 mg pantothenic acid, 4 mg pyridoxine, 0.18 mg biotin, 2 mg folic acid, 0.02 mg 





 On d 21 of the experiment, all birds per pen were euthanized using CO2. Total bone 
mineral content (BMC) and bone mineral density (BMD) were obtained per pen using a Dual X-
ray absorptiometry (DXA) scan (GE Lunar Prodigy Advance, GE-Healthcare, Boston, MA) 
located at the Applied Exercise Science Laboratory of Texas A&M University. Bone mineral 
content is defined as the total bone mineral found in a specific area measured in grams. Bone 
mineral density is derived using BMC (g) divided by an area (cm
2
) of interest. Chickens were 
placed in prone position with their wings and legs at the sides of the body throughout the scan. 
Data were analyzed using the small animal software (GE Lunar Prodigy Advanced enCore, V 




stored in a freezer (-20°C) until further analysis. The right tibiae were gently boiled for 2-h in 
water and defatted in petroleum ether for 48-h. Defatted bones were then dried in a forced draft 
oven (95°C) until a constant weight was registered (≈48 h). Finally, the dried bones were ashed 
at 650°C for 23-h. Percent tibia bone ash (TBA) was calculated based on starting dry bone 
weight and remaining ash. The left tibiae were cleaned from any adhering tissue and used to 
assay breaking strength (TBS) using a texture analyzer (TA.XT Plus, Texture Technologies, 
Hamilton, MA,) charged with a 50-kg load cell, a crosshead speed of 100 mm/min with the tibia 
supported on a 3-point bending ring and a 3-cm constant span. 
Statistical Analysis 
 Collected data were analyzed as one way-ANOVA where treatment and block were used 
as fixed factors in the model. Battery level was used as the blocking factor. Means were 
separated by Duncan’s multiple range test when appropriate. Linear and quadratic effects of 
graded levels of D3 were investigated by regression analysis. The 0 IU group was included as 
common control to investigate linear and quadratic effects. Three different regression models 
were used to calculate the D3 requirement. The one-slope straight broken-line regression model 
consists of a line with an increasing or decreasing slope and a horizontal line. The intersection 
between the two lines is the breaking point. The one-slope broken-line model is as follows: y = L 
+ U* (R-x), where (R-x) is defined as zero when x > R. The two-slope straight broken-line 
regression model is defined as y = L + U*(R-x) + V*(x-R), where (R-x) is defined as zero when 
x > R, and (x -R) is defined as zero when x < R. In the two-slope model, both intersecting lines 
have non-zero slopes. The derived parameters for both models are the breaking point x value (R), 
an asymptote for the first segment (L), and slope for the two line segments (U, V). The point of 




requirement. Finally, the quadratic broke-line model is described as y= L + U*(R-x)
2
. The 
concentration at which the response reached 95% of the minimum response was estimated as the 
D3 requirement (Robbins, 1986; Robbins et al., 2006; Jiang et al., 2015). One-way ANOVA 
analysis and linear regression (linear and quadratic effects) were performed by IBM SPSS 
software (SPSS Version 25.0, SPSS Inc., Chicago, IL) and the SAS software (SAS Version 9.4, 
SAS Institute, Cary, NC) was employed for the estimation of the D3 requirement using the 
NLMIXED procedure. The Akaike Information Criterion (AIC; smaller values indicate better 
fit), coefficient of determination (R
2
) and adjusted R
2 
where used to assess the goodness of fit for 
the three models. The pen average was the experimental unit for performance and bone 
mineralization responses. Significant effects were accepted at P<0.05 for all analyses. 
 
RESULTS AND DISCUSSION 
Performance 
 Performance results are presented in table 10. No differences (P>0.05) were observed in 
BW of broiler chickens orally gavaged with D3. The D3 treatments positively improved (P<0.05) 
WG and FE. There was no linear or quadratic effect with increasing concentration of D3 for any 
of the performance variables. However, WG linear effect approached significance (P=0.059) and 
FE quadratic response approached significance as well (P=0.057).  
 In this experiment, performance was more consistent with increasing levels of D3 when 
compared with the results of the first part of this research project. An estimation of a vitamin D3 
requirement through multiple range test was possible by looking at the Duncan’s means 
separation. Approximately, 200-400 IU/kg of feed were required to maximize BW and WG and 




this experiment when compared to the first trial, it appears that similarly, a vitamin D deficiency 
was not effectively achieved. Again, high maternal stores of D3 in the yolk reduced the 
sensitivity of our experiment and also they increased the variability in the response to graded 
levels of D3 (Moran, 2007; Coto et al., 2010a; Coto et al., 2010b; Saunders-Blades and Korver, 
2014). Another factor that could possibly have affected our results in both experiments is the 
lighting system, which consisted on fluorescent tubes covered with red plastic shields with the 
objective of reducing the possibility of endogenous synthesis of D3. However, lights were kept at 
normal intensity, and thus it was possible that some light could have potentially reached the skin 
of the chickens and endogenous synthesis of D3 was slightly induced. Edwards et al. (1994) 
reported that chickens under fluorescent light with no protection influenced broiler response to 
dietary D3 and deficiency was not successfully achieved. To investigate this further, future 
research projects should consider both protection against UV-light and intensity.  
 For the present study (second trial) FI was adjusted to better reflect the expected dietary 
concentrations of D3. This was achieved by lowering the expected ≈900 g of feed consumed over 
the last 12 d of the study to 850 g. Additionally, in this experiment the basal diet was offered as a 
crumble and not in a mash form as in the first experiment. Results of FI (Table 10) suggest that 
we effectively corrected the discrepancy between expected feed consumption and actual feed 
consumption allowing to better represent the calculated dietary concentrations of D3. Moreover, 
BW of birds used in the second experiment was closer (x̅ 85 g difference) to the expected age 
and strain BW (Cobb-700 Broiler Performance and Nutrition Supplement, 2012). Compared to 
the first experiment where FI was lower, in average there was a 240 g difference (Cobb-500 




reach their genetic potential for growth may have increased the sensitivity of the assay but not 




Table 10 Effect of dietary vitamin D3 on broiler performance  






21 d 10-21 d 10-21 d 10-21 d 
BW WG FE FI 
0  823±13  605±10ab 0.73±0.010
b
  818±11 
50 (53)  805±17  591±15b 0.73±0.010
b
  806±10 









  824±15 




  827±19 




  828±14 









  850±12 
P value     
Linear 0.1762 0.059 0.746 0.066 
Quadratic 0.995 0.578 0.057 0.258 
a-b
 Means within the same column without a common superscript differ (P<0.05) Duncan's multiple range test. 
Means ± SEM. 
1
 Calculated IU D3/kg feed (Adjusted IU D3/kg feed based on feed intake data). 
2
 Serial dilutions using the stock solution were performed to create dietary D3 treatments so that a daily constant 
dose was contained in 0.5 mL D3 was administered to the chickens through a daily oral gavage.  
3 
BW, Body weight (g/bird); WG, Weight gain (g/bird); FE, Mortality corrected feed efficiency (g weight gain / g 
feed intake), FI, feed intake (g). 
4
 Values for performance responses represent the mean average of n=6 replicate pens per treatment of 5 birds each at 











 Differences (P<0.05) in TBA and TBS were observed between treatment groups and the 
0 IU treatment group. Both TBA and TBS were linearly increased in response to dietary levels of 
D3. A quadratic response to increasing dietary levels of D3 was observed for TBS only.  
No differences (P>0.05) were detected for BMD and BMC although BMC had a linear response 
to dietary D3 levels (Table 11). Overall, BMD and BMC were not good indicators of vitamin D3 
activity in growing broilers in both experiments. Multiple range test suggest 200 IU/kg of feed 




















































 0.086±0.003 6.00±0.08 
P value     
Linear 0.003 <0.001 0.142 0.017 
Quadratic 0.229 0.016 0.697 0.642 
a-d
 Means within the same column without a common superscript differ (P<0.05) Duncan's multiple range test. 
Means ± SEM. 
1
 Calculated IU D3/kg feed (Adjusted IU D3/kg feed based on feed intake data). 
2
 Serial dilutions using the stock solution were performed to create dietary D3 treatments so that a daily constant 
dose was contained in 0.5 mL D3 was administered to the chickens through a daily oral gavage. 
3
 TBA, tibia bone ash (%); TBS, tibia breaking strength (kg force); BMD, bone mineral density (g/cm
2
); BMC, bone 
mineral content (g). 
4
 Values for bone mineralization responses represent the mean average of n=6 replicate pens per treatment of 5 birds 




 In average, a reduction of 1.5 % in TBA was obtained for this experiment. Between the 
lowest level (0 IU/kg) and the highest (3,202 IU/kg) a 2.4% reduction was achieved. Although, 
bone mineralization showed consistent responses to graded dietary levels of D3, the low 
reduction in TBA supports the results of the first experiment regarding the effect of high 
maternal stores of D3 in the egg yolk.  
Requirement Estimation Using Regression Models 
 Using three different regression models when possible, the present study determined 
different D3 requirements of chickens depending on the variable used as estimation criteria. WG 
and FE performance responses were able to fit regression models in contrast to the previous 
experiment. The vitamin D3 requirement, using the one-slope regression model, for maximum 
WG and FE was calculated at 185 and 116 IU/kg of feed respectively. Two-slope model was not 
able to fit WG but FE resulted in an estimated D3 requirement of 135 IU/kg. The quadratic model 





 were relatively low compared to bone mineralization responses (Table 12) which 
reported nutritional requirements using the one-slope model of 231 (TBA) and 251 (TBS) IU/kg 
of feed. The two-slope model estimated the D3 requirement at 466 and 111 for TBA and TBS 
respectively. Finally, the quadratic model reported in agreement with the first experiment higher 
requirements than the linear models. TBA was found to be maximized at 350 IU/kg and TBS 
was maximized at 300 IU/kg.  
 Compared to the requirements calculated in the first experiment, this study generally 
supports the NRC (1994) D3 requirement of 200 IU /kg of feed. A reduction in the D3 
requirement was expected as Ca and non-phytate phosphorus (NPP) were not reduced in the diet 




chickens are fed adequate amounts of Ca and NPP, the D3 requirement will be around the 200 
IU/kg of feed between 1 and 21 days post-hatch. However, changes in NPP in the diet can 
increase the D3 requirement up to 1,500 IU/kg (Baker et al., 1998). Similarly, Rama Rao et al. 
(2006) concluded that performance and bone mineralization in broilers could be maintained with 
suboptimal concentration of Ca and NPP (0.5% and 0.25% respectively) with high dietary 





















One-slope straight broken line 185 455.40 0.158 -0.015 
Quadratic broken line 253 456.00 0.148 -0.027 
FE 
One-slope straight broken line 116 -247.5 0.212 0.050 
Two-slope straight broken line 135 -247.4 0.243 0.087 
Quadratic broken line 201 -246.7 0.199 0.034 
TBA 
One-slope straight broken line 231 143.10 0.317 0.177 
Two-slope straight broken line 466 147.20 0.286 0.140 
Quadratic broken line 350 143.40 0.313 0.172 
TBS 
One-slope straight broken line 251 178.80 0.438 0.322 
Two-slope straight broken line 111 176.60 0.486 0.380 
Quadratic broken line 300 177.40 0.454 0.342 
1
 WG, weight gain (g); FE, feed efficiency (g/g); TBA, tibia bone ash (%); TBS, tibia breaking strength (kg force) 
2
 The one-slope straight broken-line regression model is y = L + U* (R- x), where (R-x) is defined as zero when x > 
R. The two-slope straight broken-line regression model is defined as y = L + U* (R- x) + V *(x-R), where (R − x) is 
defined as zero when x > R, and (x − R) is defined as zero when x < R. The derived parameters for both models are 
the breaking point x value (R), an asymptote for the first segment (L), and slope for the two line segments (U, V).    




 Estimated requirement, ER (IU D3/ kg of feed). 
4







 In contrast, Kasim and Edwards (2000) estimated the D3 requirement for growing broiler 
chickens ranging from 800-1,100 IU/kg of feed to maximize final BW, feed conversion ratio, 
plasma Ca and bone ash in broiler chickens fed adequate amounts of C and NPP. Whitehead et 
al. (2004) reported that the D3 requirement of growing broilers up to 14 days of age at sufficient 
dietary Ca and available P may be in the range of 1,400-2,000 IU/kg of feed based on maximum 
cortical bone quality and 10,000 IU/kg of feed required for prevention of tibial dyschondroplasia. 
 There is a considerable variation in the published D3 requirement for broiler chickens. 
Whether some literature reports base their estimation of the D3 requirement on multiple range 
test only and other use very complex regression models, the resulting D3 requirement appear to 
be very different. The development of this protocol had the objective of reducing the errors 
associated with classical methodologies to estimate nutritional requirements. From our 
perspective, the present protocol allows an estimation of the vitamin D3 requirement. However, it 
is highly influenced by the maternal reserves of D3 found in the egg yolk. If a D3 deficiency is 
not observed the sensitivity of the assay will be highly reduced. Therefore, our future efforts will 
be placed on developing new protocols to obtain broiler chickens with a more homogenous 
vitamin D background and estimate the vitamin D3 requirement with a minimum carryover effect 
from the breeder flock. A good approach could be obtaining a breeder flock and depleting the 
birds from D3 for a period of time, expecting the resulting progeny will have a more homogenous 
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EVALUATION OF DIETARY CHOLECALCIFEROL AND 25-
HYDROXYCHOLECALCIFEROL ON BROILER CHICKENS SUBJECTED TO A 
COCCIDIOSIS VACCINE CHALLENGE 
 
INTRODUCTION 
 Traditionally, cholecalciferol or vitamin D3 (D3) has been supplemented to poultry feeds 
as a strategy to prevent skeletal disorders in commercial meat-type poultry. Active participation 
in P and Ca homeostasis confers vitamin D3 a potent antirachitic activity (Collins and Norman, 
2001). However, vitamin D3 is not considered biologically active until it undergoes a series of 
hydroxylation reactions in the body. First, D3 obtained from the diet or synthesized in the skin, 
after UV-irradiation, is transported to the liver where it is converted into 25-
hydroxycholecalciferol (25-OH-D3), the major circulating metabolite of D3. Newly synthesized 
25-OH-D3 is then transported to the kidneys where it undergoes a second hydroxylation and it is 
converted into 1,25-dihydroxycholecalciferol, the fully active form of D3 (Leeson and Summers, 
2001).  
  There are literature reports suggesting that dietary 25-OH-D3 in replacement or in 
addition to D3 is effective in promoting performance, enhancing bone mineralization, reducing 
incidence of tibial dyschondroplasia (Whitehead, 1995; Yarger et al., 1995; Fritts and Waldroup, 
2003; Ledwaba and Roberson, 2003; Atencio et al., 2005; Han et al., 2016), improving intestinal 
morphology (Chou et al., 2009), and regulating avian immunity (Gómez-Verduzco et al., 2013; 
Morris et al., 2014; Morris et al., 2015). Thus, the use of commercially available D3 metabolites 




 Coccidiosis in poultry is a protozoal infection caused by coccidia from the genus Eimeria 
and it is characterized by the destruction of the intestinal mucosa, hemorrhages, dehydration, and 
reduced performance (Merck Veterinary Manual, 2010; Peek and Landman, 2011). Coccidiosis 
is one of the most economically important diseases affecting the commercial poultry industry. 
Just for the broiler industry, around $3 billion USD are spent worldwide every year in the 
prevention of coccidiosis (Anon., 2013). Live anticoccidial vaccines are widely used to prevent 
and control coccidiosis in commercial poultry facilities (De Gussem, 2007). Current delivery 
strategies of live vaccines consist on oocysts suspensions that are directly sprayed into the feed 
or directly sprayed into newly-hatched chicks allowing them to ingest the oocysts by preening 
themselves and each other (Dalloul and Lillehoj, 2005). The use of live vaccines is associated 
with the development of sub-clinical infection and therefore, potential reduction in performance 
(Peek and Landman, 2011; Ahmad et al., 2016). Recent studies done in our laboratory suggested 
that the stress caused by the live cocci vaccine during the first weeks of life could be reduced 
with supplemental prebiotic feed additives (Al-Ajeeli et al., 2017). Due to the known effects of 
D3 on performance, bone mineralization, and avian immunity, a similar approach may be taken 
using D3 and 25-OH-D3 at high dietary levels, usually used in the commercial poultry industry, 
to compare their effectiveness in ameliorating the negative effects of live coccidial vaccines. 
Hence, the present study was conducted with the objective of comparing the effect of high 
dietary levels of D3 and partial replacement of D3 with 25-OH-D3 on performance, bone 
mineralization, intestinal integrity, vitamin D status, and plasma cytokine levels of broiler 






MATERIALS AND METHODS 
 All procedures in this experiment were approved by the Institutional Animal Care and 
Use Committee of Texas A&M University (AUP: IACUC 2017-0072). 
Birds and General Management 
 A total of 300 Cobb-700 1-d-old male broiler chickens were procured from a commercial 
hatchery. At the time of arrival to the experimental facilities, the birds were weighed in groups of 
20 and an average body weight (BW) was calculated. The average BW was used to create 45 
groups of six chickens (n=288) with close to “identical” starting body weight and variance. 
Broilers were then allocated to two stainless steel battery brooders (6 birds per cage and 5 pen 
replicates per treatment) inside an environmentally controlled rearing room using a completely 
randomized block design. Battery pen level (5 levels) was used as the blocking factor. 
Fluorescent 48-inch tube lamps covered with red plastic shields, were used to provide 24-h 
constant light. The complete absence of UV-light inside the rearing rooms has been previously 
verified (Fowler et al., 2014) by the Texas A&M Environmental Health and Safety Office using 
a short wave UV meter (J-225 Blak-Ray, UVP, LLC. Upland, CA). Treatment diets were offered 
ad libitum throughout the 21-d trial period. Water was offered ad libitum using nipple drinkers. 
Birds were monitored daily with regard to general flock condition, temperature, lighting, water, 
feed, and any unanticipated events inside the rearing facility. 
Dietary Treatments 
 A basal D3-deficient corn-soy broiler starter diet was formulated using a custom made 
vitamin / mineral premix containing no D3 and corn oil as the fat source (Table 13). To increase 
the sensitivity of our response variables to the supplemental D3 and 25-OH-D3 products, the 




Table 13 Basal vitamin D3 deficient diet 
Ingredient   Basal Diet 
1
 (%) 
Yellow corn 63.07 




Corn oil 1.67 
Limestone 1.07 
Monocalcium phosphate 1.19 
Sodium chloride (salt) 0.44 
Sodium bicarbonate 0.03 




Calculated nutritional content was as follow: 22% crude protein, 3,050 kcal/kg metabolizable energy, 0.75% 
calcium, 0.37% non-phytate phosphorous, 0.61% methionine, 0.98% methionine+cystine, 1.32% lysine, 0.26% 




Vitamin-mineral premix added at this rate yields per kg of diet: 10 mg copper, 2 mg iodine, 20 mg iron, 125 mg 
manganese, 125 mg zinc, 0.2 mg selenium, 8,000 IU vitamin A, 40 IU vitamin E, 2 mg menadione, 4 mg thiamine, 8 
mg riboflavin, 60 mg niacin, 15 mg pantothenic acid, 4 mg pyridoxine, 0.18 mg biotin, 2 mg folic acid, 0.02 mg 




 The basal diet was then subdivided into nine equally sized batches to create the 
experimental treatments. Treatments consisted of the basal diet plus the supplementation of a 
commercially available D3 source (D3-30 [30,000 IU D3/g or 750 μg D3/g], Animal Science 
Products Inc., Nacogdoches, TX) at 200 (control diet; CON), 2,000 , 4,000, 6,000 and 8,000 IU 
D3 per kg of feed (5, 50, 100, 150, 200 μg D3/kg of feed) or the basal diet supplemented with the 
same D3 source at 1,000, 2,000, 3,000 and 4,000 IU D3 per kg of feed ( 25, 50, 75, 100 μg D3/kg 
of feed) in combination with  25, 50, 75 and 100 µg 25-OH-D3 (Bio-D, Huvepharma Inc., 
Peachtree, GA) per kg of feed (Table 14) respectively, and calculated to be equivalent to 1,000, 




into one IU (NRC, 1994). All treatment diets were offered ad libitum as crumbles throughout the 
21 d trial period.  
Coccidia Vaccine Challenge 
 On d 7 of the study, all birds were orally gavaged with a commercially available live 
coccidiosis vaccine (ADVENT-Vaccine, Huvepharma Inc., Peachtree, GA) containing a mixture 
of viable sporulated oocysts (E. acervulina, E. maxima and E. tenella) at 7x recommended dose. 
Oocysts were delivered using a 20-gauge stainless steel gavage needle and a 3 mL syringe. A 
total of 0.5 mL containing the oocysts where delivered directly into the crop to induce coccidial 
infection.  
Performance Evaluation 
 Feed intake (FI) and BW per pen were recorded on d 7, 14 and 21 to calculate weight 
gain (WG), and feed conversion ratio (FCR). Mortality and body weight of dead birds were 
recorded daily and used to adjust FCR.  
Vitamin D Status and Plasma Cytokine Levels 
 Blood samples were drawn from one bird per pen at d 14 (7-d post-challenge). Blood 
samples were collected within Vacutainer EDTA tubes (BD, Franklin Lakes, NJ) and centrifuged 
for 15 min at 1000 x g and 5°C immediately after collection. Two plasma aliquots were collected 
within 1 mL micro centrifuge tubes. After processing, the plasma samples were immediately 
stored at -20 °C until further analysis. Vitamin D status (VDS) was determined by total plasma 
25-OH-D3 concentration using a commercially available ELISA kit (25-OH-Vitamin D Kit Eagle 
Biosciences, Nashua, NH, Ref:VID91-K01; Assay range 9-150 ng/mL). Plasma samples were 





Table 14 Experimental treatment details 
TRT μg D3/kg feed 
25-OH-D3 µg 
/kg feed* 
Analyzed D3  




µg /kg feed 
TI (Control)
1
 5  12 <5 
T2 50  68 <5 
T3 100  64 <5 
T4 150  97 <5 
T5 200  138 <5 
T6 25 25 52 19.6 
T7 50 50 50 37.4 
T8 75 75 66 55.0 
T9 100 100 90 81.9 
1
 NRC (1994) Cholecalciferol requirement for starting meat-type chicken (200 IU/kg feed or 5 μg/kg of feed)  
*Bioactivity of all products is based on 1:1 conversion of 1 IU D3= 0.025µg cholecalciferol 
** Experimental treatments were chemically analyzed at Heartland Assays Laboratories (2711 s. Loop Dr. Suite 4400 




 Plasma cytokine levels were determined using commercially available ELISA kits 
(Novatein Biosciences, Inc., Woburn, MA) for chicken specific IFNγ (Ref:NB-E60048; Assay 
range 62.5-1,000 pg/mL), IL-1β (Ref:NB-E60024; Assay range 20-640 pg/mL), IL-6 (Ref:NB-
E60049; Assay range 15.6-1,000 pg/mL) and IL-10 (Ref:NB-E60092; Assay range 15.6-1,000 
pg/mL) cytokines. Plasma samples were run in triplicate and results were expressed as picograms 
per mL. 
Intestinal Morphology  
 At d 21 (14-d post-challenge) one bird per pen was randomly selected and euthanized 
using CO2. Approximately 3 cm sections of duodenum, jejunum and ileum were obtained and 




duodenum samples were taken at the middle point between the gizzard and the duodenal loop. 
The jejunum samples were taken 5 cm proximal to the Meckel’s diverticulum. The ileum 
samples were taken 5 cm proximal to the ileo-cecal junction. Intestinal samples were then 
embedded using standard paraffin wax procedures and hematoxylin-eosin stain. Villi height and 
crypt depth were measured from five well-oriented villi and villus-associated crypts for each 
sample. Villus height (VH) was measured from the tip of the villus to the villus-crypt junction. 
Crypt depth (CD) was defined as the depth of the invagination between adjacent villi (Feng et 
al., 2007). Both measurements were used to estimate villi height over crypt depth ratio 
(VH:CD). Histology slides were scanned using Leica DFC550 camera and Leica DM2500 LED 
optical microscope (Leica Microsystems, Wetzlar, Germany). Image processing and analysis was 
performed using the LAS software (Version 4.0, Leica Microsystems, Wetzlar, Germany). 
Lesion Scores and Relative Organ Weight 
 At d 21 (14-d post-challenge) of the trial, four birds per pen were weighed and euthanized 
using CO2 to score lesions in the upper (duodenum), middle (jejunum) and lower (ileum) small 
intestine and ceca. Lesions were scored from 0-4 as described by Johnson and Reid (1970). 
Where 0 score represents no gross lesions and 4 indicates severe damage to the intestine. 
Intestinal lesion scores were performed by Dr. Michael H. Kogut (USDA-ARS, College Station, 
TX) who was blinded to the experimental treatments. Lesion scores were analyzed together and 
adjusted per specific area of intestine (Perez-Carbajal, 2010).  
 To calculate relative organ weight, the liver, bursa of Fabricius, and spleen were removed 
from the same four birds. Pen average relative organ weights were calculated as percentage of 






 At d 21 (14-d post-challenge) after birds were sampled for intestinal and organ 
measurements (n=5) both tibias were removed. The right tibiae were gently boiled in water for 2-
h and defatted in petroleum ether for 48-h. Defatted bones were then dried in a forced draft oven 
(95°C) until a constant weight was registered (≈48-h). Finally, the dried bones were ashed at 
650°C for 23-h. Percent tibia ash (TBA) was calculated based on starting dry bone weight and 
remaining ash. The left tibiae were cleaned from any adhering tissue and used to assay breaking 
strength (TBS) using a texture analyzer (TA.XT Plus, Texture Technologies, Hamilton, MA,) 
charged with a 50-kg load cell, a crosshead speed of 100 mm/min with the tibia supported on a 
3-point bending ring and a 3-cm constant span. 
Statistical Analysis 
 Collected data were analyzed by one way-ANOVA where treatment and block were used 
as fixed factors in the model. Battery level (five levels) was used as the blocking factor. Lesion 
score and plasma cytokine data were analyzed using the Kruskal-Wallis test as the data were not 
normally distributed. Means were separated by Duncan’s multiple range test when appropriate. 
Linear and quadratic effects of graded levels of D3 and D3 plus 25-OH-D3 treatments were 
investigated by regression analysis. The 200 IU control group was included as common control 
for both D3 alone and D3 plus 25-OH-D3 groups to investigate linear and quadratic effects. 
Additionally, orthogonal contrasts were employed to investigate particular effects of interest. 
The pen average was the experimental unit for performance, bone mineralization, lesion scoring 
and relative organ weight responses. Individual birds were the experimental unit for vitamin D 




performed using IBM SPSS software (SPSS Version 25.0, SPSS Inc., Chicago, IL) and 
significant differences were accepted at P<0.05 for all analyses. 
 
RESULTS AND DISCUSSION 
Performance 
 Performance results are presented in table 15. The BW and WG of 7-d broiler chickens 
was not different (P>0.05) across the D3 and D3+25-OH-D3 dietary treatments. However, FCR of 
birds consuming dietary D3 or D3+25-OH-D3 was improved when compared with the CON 
group (5 μg D3/ kg). A quadratic response was observed in FCR of broiler chickens being fed 
increasing dietary levels of D3. The BW, WG and FCR of chickens linearly improved with 
increasing dietary levels of D3+25-OH-D3 after 7 d. Similar results were observed after 14 d of 
the trial. The WG of broiler chickens consuming the CON diet was significantly lower than all 
other D3 and D3+25-OH-D3 dietary treatments. After 14-d on treatment diets, linear responses 
were found for FCR of chickens fed D3 alone, and BW and WG of chickens offered the D3+25-
OH-D3 combination treatments. Quadratic responses were observed for WG of chickens fed D3 
alone and the FCR of chickens fed the combined D3+25-OH-D3 dietary treatments. Finally, at the 
end of the trial (21-d) differences (P<0.05) were observed in all performance variables. The BW, 
WG and FCR of broilers were improved compared to the CON group. The WG and FCR of 21-d 
chickens were linearly improved with increasing dietary levels of D3 while the D3+25-OH-D3 
dietary treatments had a quadratic response for the same response variables. The BW of 21-d 














 7d 0-7d 0-7 d 14 d 7-14 d 7-14 d 21 14-21 d 14-21 d 
 BW WG  FCR BW  WG  FCR BW  WG  FCR 
       5 (Control) T1 160±3 114±3 1.26±0.03a 440±7 280±5b 1.32±0.01a   858±20b   418±14b 1.44±0.01a 
50  T2 172±4 127±4 1.16±0.01b 476±9 304±5a 1.28±0.01b 956±9a 479±8a 1.35±0.01b 
100  T3 166±6 121±6 1.16±0.01b   466±10 300±5a 1.28±0.01b   924±21a   458±13a 1.38±0.01b 
150  T4 165±3 119±3 1.20±0.01b 464±8 299±6a 1.28±0.01b   927±11a 463±6a 1.35±0.01b 
200  T5 167±5 121±5 1.18±0.01b 466±9 299±5a 1.28±0.01b 935±8a 470±2a 1.36±0.02b 
25 25 T6 167±6 122±6 1.20±0.03b   469±14 302±9a 1.27±0.01b   944±20a   475±10a 1.36±0.02b 
50 50 T7 169±1 124±1 1.19±0.01b 475±3 306±4a 1.28±0.01b   955±10a 481±8a 1.38±0.01b 
75 75 T8 174±4 128±4 1.15±0.02b 479±9 305±5a  1.30±0.01ab   949±23a 470±6a 1.39±0.03b 
100 100 T9 176±2 130±3 1.17±0.01b 485±8 309±6a  1.30±0.01ab   934±18a    449±14ab 1.38±0.02b 
P value  
Vit. D3            
Linear  0.716 0.730 0.082 0.222 0.094 0.006 0.055 0.036 0.007 
Quadratic  0.386 0.355 0.017 0.093 0.037 0.063 0.047 0.075 0.024 
Vit. D3 + 25-OH-D3           
Linear  0.002 0.002 0.003 0.002 0.004 0.689 0.039 0.291 0.282 
Quadratic  0.507 0.373 0.086 0.145 0.075 0.038 0.005 0.001 0.010 
Contrasts           
x̅ T1-T5 vs x̅ T6-T9 0.056 0.046 0.130 0.024 0.024 0.892 0.037 0.167 0.699 
x̅ T2-T5 vs x̅ T6-T9 0.179 0.160 0.928 0.179 0.235 0.312 0.430 0.909 0.333 
a-b
 Means within the same column without a common superscript differ (P<0.05) Duncan’s multiple range test; Means± SEM. 
1
25-hydroxycholecalciferol (25-OH-D3) supplemented levels were calculated to be equivalent to 1,000, 2,000, 3,000 and 4,000 IU of D3 activity based on the 
conversion of 0.025 μg of cholecalciferol into one IU (NRC, 1994). 
2
 BW, Body weight (g/bird); WG, Weight gain (g/bird); FCR, Mortality corrected feed conversion ratio (g feed intake / g weight gain). 
3





 In this experiment, overall performance of the birds was improved with the 
supplementation of D3 or D3+25-OH-D3 dietary treatments above the NRC (1994) 
recommendations of 5 μg D3/ kg of diet. However, no consistent differences were detected 
between dietary sources of D3. Our results are agreement with Bar et al. (2003) who conducted 
five experiments to compare the effects of dietary 25-OH-D3 to D3 alone on broiler chickens. 
From the five experiments, only one resulted in an improvement in performance of 22-d old 
broilers. In the other experiments, the growth response was similar between dietary D3 sources. 
Interestingly, the experiment where performance was positively influenced by 25-OH-D3 used a 
Ca and NPP restriction in the diet similar to the one used in this experiment. These results 
support the hypothesis of Baker et al (1998) that lowering the Ca and NPP in the diet in fact 
increases the dietary requirement of D3. Moreover, in agreement with the results of this 
experiment and Baker et al. (1998) conclusions, Ledwaba and Roberson (2003) reported that the 
effectiveness of dietary 25-OH-D3 to positively influence performance and bone characteristics 
was higher when diets were fed with suboptimal Ca levels (0.80 to 0.85%). Therefore, the use of 
25-OH-D3 as partial replacement of D3 in poultry diets could provide a more effective margin of 
safety in preventing performance reductions in the presence of low Ca or NPP diets. 
 A second factor influencing the bird’s need for higher dietary D3 is the presence of 
intestinal parasites such as coccidia (Leeson and Summers, 2001). In this experiment, a live 
coccidiosis vaccine was used to challenge the immune and digestive system of the bird. The use 
of live vaccines is usually associated with reduced performance due to the induced subclinical 
infection after vaccination (Lillehoj and Trout, 1993). Thus, the results of this experiment 
suggest that dietary supplementation of D3, independent of the source, is effective in ameliorating 




Vitamin D Status and Plasma Cytokines 
 Vitamin D status (VDS) of 14-d broiler chickens increased linearly (P<0.05) with 
increasing concentrations of D3 and D3+25-OH-D3 combination treatments. A quadratic response 
was observed for the D3+25-OH-D3 treatments only. Additionally, VDS of the CON group was 
different (P<0.05) from all other treatments. The 50, 100, and 150 μg of D3 alone treatment 
groups were significantly lower than all D3+25-OH-D3 treatments. Moreover, D3+25-OH-D3 
dietary treatments (Contrast [x̅ T2-T5 vs x̅ T6-T9]) were found to be significantly higher than all 
equivalent μg of D3 treatments offered as D3 alone (Table 16).  
 Vitamin D status of 14-d old broiler chickens increased linearly for both D3 and D3+25-
OH-D3 dietary treatments. Additionally, plasma 25-OH-D3 concentration was higher in all 
D3+25-OH-D3 dietary treatments compared to their equivalent D3 treatments. In agreement with 
the results of this experiment, Clark and Potts (1977) found that there was a linear relationship 
between the intake of vitamin D3 and the serum levels of 25-OH-D3. Also, Yarger et al. (1995a) 
compared the effect of feeding D3 or 25-OH-D3 at different concentration levels and found a 
significant dose response with serum 25-OH-D3 concentrations increasing more rapidly in birds 
fed 25-OH-D3 than in birds fed D3 alone. Plasma or serum 25-OH-D3 is considered to be the best 
indicator of VDS because of its ability to respond to the source and dietary level of D3.  
 The improvement of VDS appears to have a relationship with improved BW and FCR 
(Yarger et al., 1995a). Although this relation was not very clear in this experiment, previous 
literature reports indicate that dietary 25-OH-D3 is more effective than D3 in improving overall 





Table 16 Effect of dietary vitamin D3 and 25-hydroxycholecalciferol on plasma vitamin D 














   IFN-γ IL-1β IL-6 IL-10 
      5(Control) T1 25.1±6.3
f
 306±86 43±16 294±258 190±90 
50  T2 55.1±8.1
e
 291±248 62±20 4±1 40±23 
100  T3 92.5±8.7
d
 637±459 91±17 589±477 396±213 
150  T4 96.0±8.2
d
 367±219 74±32 256±180 222±172 
200  T5 116.4±2.1
c
 870±421 405±294 295±277 369±221 
25 25 T6  125.9±6.2
bc
 95±62 60±29 206±202 51±47 
50 50 T7  138.4±3.4
ab
 105±97 63±30 92±88 61±30 
75 75 T8 146.9±0.3
a
 692±469 22±12 53±30 419±317 
100 100 T9 149.6±0.9
a
 185±109 62±31 397±193 86±65 
P value       
Vit. D3       
Linear  <0.001  
Quadratic  0.081 
Vit. D3 + 25-OH-D3   
Linear  <0.001 
Quadratic  <0.001 
Contrasts   
x̅ T1-T5 vs x̅ T6-T9 <0.001 
x̅ T2-T5 vs x̅ T6-T9 <0.001 
a-f
 Means within the same column without a common superscript differ (P<0.05) Duncan’s multiple range test. 
Means± SEM. 
1
25-hydroxycholecalciferol (25-OH-D3) supplemented levels were calculated to be equivalent to 1,000, 2,000, 3,000 
and 4,000 IU of D3 activity based on the conversion of 0.025 μg of cholecalciferol into one IU (NRC, 1994). 
2
 VDS, Vitamin D status (ng/mL) is defined as the total plasma concentration of circulating 25-OH-D3; IFN-γ 
(pg/mL); IL-1β (pg/mL); IL-6(pg/mL); IL-10 (pg/mL);  
3
 Values for vitamin D status and cytokines represent the mean of n=5 replicate birds per treatment. 




 This relationship was further investigated by Hutton et al. (2014), who compared the 




broiler chickens. They found higher circulating levels of D3 in the broilers fed the D3+25-OH-D3, 
although overall performance was not improved among treatments.  
 The ability of D3+25-OH-D3 treatments to increase VDS higher than D3 alone after the 
coccidiosis vaccine challenge could represent a better strategy to reduce the negative effects of 
live coccidiosis vaccines in young growing broilers.  
 Plasma cytokine concentration assayed by the ELISA kits resulted in high variability 
across D3 treatments (Table 16). No differences (P>0.05) were detected between D3 sources for 
any of the plasma cytokines assayed in this experiment. However, IL-1β, a cytokine associated 
with inflammatory response, cell differentiation and apoptosis regulation in the body (Giraldo et 
al., 2009), appeared to have numerically lower concentrations than all other cytokines measured 
in this experiment (IFN-γ, IL-6, and IL-10) except for the 200 μg of D3 treatment which reported 
a high concentration with respect other treatment groups. No differences in plasma cytokines 
were observed between the CON group and the graded D3 treatments either.  
 IL-10 is known to inhibit the synthesis of pro-inflammatory cytokines such as, IL-1β and 
IL-6 (Hong et al., 2006). A concentration increase of IL-10 in the plasma would indicate an anti-
inflammatory response of dietary D3. This relationship was observed by Morris et al. (2015) who 
reported that 25-OH-D3 influenced in vitro expression of IL-10 mRNA using chicken 
macrophage cell lines. Additionally, an in vivo study conducted by the same research team using 
layer-type chicks orally challenged with 1×10
5
 live coccidia oocysts at 21-d of age and 
supplemented with 6.25, 25, or 50 μg of 25-OH-D3 per kg of feed revealed evidence suggesting 
dietary 25-OH-D3 has a regulatory effect on body weight, CD8+ cells, IL-10 mRNA expression 
and CD4+CD25+ cells. Moreover, dietary 25-OH-D3 supplementation (100µg/kg) decreased IL-




experiment did not provide enough information to either support or not support the 
immunomodulatory role of D3 after cocci vaccine challenge.  
Intestinal Integrity and Relative Organ Weight 
 No differences (P>0.05) in gross coccidial lesions were observed after 14-d of the 
coccidiosis vaccine across dietary treatments or the upper (duodenum), middle (jejunum), lower 
intestine (ileum) and the ceca of 21-d broiler chickens. Comparing the different intestine 
sections, very mild lesions were detected in the medium and lower intestine and almost no 
lesions were detected in the ceca. The majority of lesions were detected in the upper section of 
the intestine but were not affected by dietary treatment (Table 17).  
 The presence of lesions confirms that I effectively delivered the coccidiosis vaccine to 
the chickens and therefore there was a digestive and immune challenge to the birds. However, 
the low severity of the lesions observed across the different sections of the intestine and that no 
treatment differences were detected in this experiment suggests that there was a mild non-clinical 
challenge to the birds. This is expected because the caging system did not allow recycling of the 
oocysts. Further research projects investigating similar effects of vitamin D3 using facilities that 
do not allow recycling of the oocysts may consider increasing the dose of the coccidiosis vaccine 
challenge. 
 Intestine histology results are presented in table 18. Differences (P<0.05) between dietary 
treatments were observed in VH:CD ratio of the duodenum only. A linear increase (P<0.05) in 
duodenum villi height was observed with increasing dietary levels of D3+25-OH-D3 and a 
quadratic response (P<0.05) to graded level of D3+25-OH-D3 was observed in ileum villi height. 
 No differences (P>0.05) were observed in any villi height, crypt depth or associated ratio in the 




Table 17 Effect of dietary vitamin D3 and 25-hydroxycholecalciferol on lesion scores of 21- 














U  M  L C  
      5 (Control) T1 0.50±0.18 0.30±0.15 0.06±0.06 0.00±0.00 
50  T2 0.55±0.15 0.10±0.61 0.00±0.00 0.05±0.05 
100  T3 0.75±0.14 0.10±0.61 0.15±0.10 0.00±0.00 
150  T4 0.32±0.12 0.00±0.00 0.10±0.06 0.00±0.00 
200  T5 0.80±0.27 0.21±0.15 0.12±0.07 0.00±0.00 
25 25 T6 0.55±0.15 0.20±0.01 0.05±0.05 0.00±0.00 
50 50 T7 0.65±0.17 0.05±0.05 0.10±0.10 0.00±0.00 
75 75 T8 0.35±0.17 0.25±0.08 0.05±0.05 0.00±0.00 
100 100 T9 0.73±0.28 0.10±0.06 0.27±0.08 0.00±0.00 
Means± SEM. 
1
25-hydroxycholecalciferol (25-OH-D3) supplemented levels were calculated to be equivalent to 1,000, 2,000, 3,000 
and 4,000 IU of D3 activity based on the conversion of 0.025 μg of cholecalciferol into one IU (NRC, 1994). 
2
 Chickens were vaccinated (7x recommended dose) on day 7 of the trial. Lesions were scored from 0-4 as described 
by Johnson and Reid (1970). Where 0 score represents no gross lesions and 4 indicates severe damage to the 
intestine. Data were analyzed by Kruskal-Wallis test.  
3
 U, Upper intestine (duodenum); M, Medium intestine (jejunum); L, Lower intestine (ileum); C, Ceca;  
4




  Although not consistent, villi height in the duodenum of chickens fed D3 and D3+25-OH-
D3 diets was numerically higher. Also, V:C ratio in the duodenum and in the ileum had a similar 
response, suggesting an increase in nutrient absorption in the upper and lower sections of the 
intestine. Similar results were found by Chou et al. (2009) who reported that supplemental 25-
OH-D3 positively influenced small intestine morphology; villi height of the duodenum and 






 In the experiment of Chou et al. (2009), intestinal morphology was evaluated in the 
absence of a pathogen or parasite challenge. It is possible that the coccidiosis vaccine caused an 
increased variability in the intestinal response of the chickens to supplemental D3. Even when the 
same vaccine dose was administered to all chickens, some of them were likely more resistant 
than others to infections and parasite infestations. Moreover, the presence of coccidia in the 
intestine could have resulted in alterations in the intestinal morphology. There are some literature 
reports (Yamauchi, 2002; Khambualai et al., 2009; de Verdal et al., 2010) that suggest the 
intestine is highly reactive to nutritional or histological alterations. Yamauchi (2002) described 
how a compensatory enlargement of ileal villi is induced after a disturbance of the natural 
histology of the intestine. Further research investigating histological variables in the presence of 
pathogens or parasites is recommended to better understand the role of D3 and 25-OH-D3 in the 
intestinal morphology.  
 Overall, no differences (P<0.05) were observed in relative organ weight of broiler 
chickens after 21-d (Table 19). Differences in the relative weight of the bursa of Fabricius were 
observed between D3 and D3+25-OH-D3 treatments. In average (Contrast [x̅ T2-T5 vs x̅ T6-T9]) 
the D3+25-OH-D3 treatment groups had smaller bursas of Fabricius and bigger livers than the D3 
treatments. 
 Relative weight of immune organs such as the spleen, bursa of Fabricius and liver is a 
method of evaluating overall immune status of the chicken (Heckert et al., 2002). Reduced 
growth of these organs could be thought of compromised immunity (Zhou et al., 2009). Relative 
weight of livers in this experiment was higher for the D3+25-OH-D3 treatments on average (x̅ 














Response (14-d post- cocci challenge)
2,3 
 VH-D CD-D  V:C-D VH-J CD-J  V:C-J VH-I CD-I  V:C-I 
       5 (Control) T1 2500±87  194±20  13.4±1.2bc 1434±89  180±15 8.1±0.7 949±90  171±29 6.1±0.9 
50  T2 2628±128 138±7 19.2±2.0a  1459±151  180±10 8.1±1.6 827±41  158±11 5.3±0.1 
100  T3 2508±93  198±15  12.9±1.2bc 1599±73  193±17 8.5±0.8 927±67  168±15 5.7±0.7 
150  T4 2708±129  157±18 18.2±2.2a  1360±126 156±8 8.7±0.6 865±68  153±10 5.7±0.2 
200  T5 2635±58  203±16  13.2±0.7bc  1467±109  184±20 8.4±1.2 932±60 148±7 6.3±0.3 
25 25 T6 2455±123  209±19 12.2±1.6c  1239±125  170±17 7.6±1.2 844±50  128±16 7.0±0.8 
50 50 T7 2621±58 156±8  16.9±0.8ab 1314±60  170±13 8.0±0.9 766±46  159±15 5.0±0.3 
75 75 T8 2754±40  183±17  15.5±1.3abc 1348±48  158±12 8.6±0.5 798±32  130±14 6.4±0.5 
100 100 T9 2714±90  212±19  13.0±0.7bc 1374±90  165±13 8.5±0.8 954±53  135±14 7.3±0.7 
P value  
Vit. D3            
Linear  0.250 0.612 0.907 0.932 0.744 0.671 0.961 0.300 0.619 
Quadratic  0.845 0.203 0.188 0.742 0.786 0.825 0.413 0.892 0.248 
Vit. D3 + 25-OH-D3           
Linear  0.010 0.791 0.611 0.884 0.289 0.504 0.735 0.251 0.582 
Quadratic  0.823 0.095 0.051 0.223 0.675 0.756 0.007 0.625 0.223 
Contrasts           
x̅ T1-T5 vs x̅ T6-T9 0.358 0.524 0.333 0.067 0.228 0.647 0.103 0.031 0.180 
x̅ T2-T5 vs x̅ T6-T9 0.240 0.825 0.157 0.068 0.279 0.573 0.209 0.209 0.154 
a-c
 Means within the same column without a common superscript differ (P<0.05) Duncan’s multiple range test; Means± SEM. 
1
25-hydroxycholecalciferol (25-OH-D3) supplemented levels were calculated to be equivalent to 1,000, 2,000, 3,000 and 4,000 IU of D3 activity based on the 
conversion of 0.025 μg of cholecalciferol into one IU (NRC, 1994). 
2
 VH, villi height (µm); CD, crypt depth (µm); V:C, villi height /crypt depth ratio; D, duodenum; J, jejunum; I, ileum.  
3




Table 19 Effect of dietary vitamin D3 and 25-hydroxycholecalciferol on relative organ 







 Response (14-d post-cocci challenge)
2,3
 
   Liver Spleen Bursa 
      5 (Control) T1 2.98±0.05 0.12±0.01  0.16±0.01
abc
 
50  T2 2.82±0.08 0.13±0.01  0.17±0.01
ab
 
100  T3 2.86±0.05 0.12±0.01 0.18±0.01
a
 
150  T4 2.90±0.06 0.11±0.01   0.15±0.01
abcd
 
200  T5 3.00±0.06 0.13±0.01   0.15±0.01
abcd
 
25 25 T6 3.11±0.07 0.12±0.01 0.12±0.01
d
 
50 50 T7 3.03±0.07 0.11±0.01 0.14±0.01
cd
 
75 75 T8 3.02±0.06 0.12±0.01   0.15±0.01
abcd
 
100 100 T9 3.03±0.06 0.11±0.01    0.14±0.01
abcd
 
P value  
Vit. D3     
Linear  0.576 0.934 0.282 
Quadratic  0.051 0.628 0.210 
Vit. D3 + 25-OH-D3     
Linear  0.930 0.583 0.785 
Quadratic  0.464 0.993 0.171 
Contrasts     
x̅ T1-T5 vs x ̅ T6-T9 0.003 0.250 <0.001 
x̅ T2-T5 vs x ̅ T6-T9 0.002 0.223 <0.001 
a-d
 Means within the same column without a common superscript differ (P<0.05) Duncan’s multiple range test; 
Means± SEM. 
1
25-hydroxycholecalciferol (25-OH-D3) supplemented levels were calculated to be equivalent to 1,000, 2,000, 3,000 
and 4,000 IU of D3 activity based on the conversion of 0.025 μg of cholecalciferol into one IU (NRC, 1994). 
2
 Liver, spleen and bursa are expressed as g/100g body weight 
3




 In contrast, the D3+25-OH-D3 treatments also tended to have smaller bursas of Fabricius 
(x̅ T2-T5 vs x̅ T6-T9) and may indicate reduced immune capacity. Unfortunately, with the lack 
of non-vaccinated controls in this experiment to have a reference of “normal growth,” we cannot 






 Bone mineralization results are presented in table 20. Both TBA and TBS differences 
(P<0.05) were observed across dietary treatment groups. Overall the supplementation of D3 
alone or D3+25-OH-D3 improved (P<0.05) TBA and TBS with respect to the CON treatment. 
TBS of 21-d broiler chickens had a linear and quadratic response to increasing concentrations of 
D3 or D3+25-OH-D3. TBA resulted in a linear increase to dietary D3 and both a linear and 
quadratic effect was observed for D3+25-OH-D3 treatment groups. For both bone mineralization 
responses (TBA & TBS), D3+25-OH-D3 dietary treatments (Contrast [x̅ T2-T5 vs x̅ T6-T9]) 
were found to be significantly higher than all equivalent treatments offered as D3 alone.  
 Bone mineralization results of the present experiment are in agreement with literature 
reports suggesting that dietary D3 alone or in combination with 25-OH-D3 enhances bone health 
(Kasim and Edwards, 2000; Fritts and Waldroup, 2003; Whitehead et al., 2004; Rama Rao et al., 
2006; Khan et al., 2010; Vazquez et al., 2018). In average, TBA was improved ≈3.5% when the 
D3 (>50 μg D3/kg) and D3+25-OH-D3 treatment groups where compared to the CON group. 
Between D3 and D3+25-OH-D3 sources TBA was improved an average of ≈1.3%. Similarly, TBS 
was improved ≈6 kg of force when all the D3 and D3+25-OH-D3 treatment groups where 
compared to the CON group and ≈2 kg of force when the D3 alone was compared to the D3+25-
OH-D3 treatment groups. The effectiveness of dietary 25-OH-D3 in promoting bone 
mineralization is related with its higher bioactivity which is reported to be around 1.6 to 2.0 






Table 20 Effect of dietary vitamin D3 and 25-hydroxycholecalciferol on bone mineralization 
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P value  
Vit. D3    
Linear  0.086 0.001 
Quadratic  0.004 0.001 
Vit. D3 + 25-OH-D3    
Linear  0.002 <0.001 
Quadratic  0.001 <0.001 
Contrasts    
x̅ T1-T5 vs x ̅ T6-T9 <0.001 <0.001 
x̅ T2-T5 vs x ̅ T6-T9 <0.010 <0.010 
a-d
 Means within the same column without a common superscript differ (P<0.05) Duncan’s multiple range test; 
Means± SEM. 
1
25-hydroxycholecalciferol (25-OH-D3) supplemented levels were calculated to be equivalent to 1,000, 2,000, 3,000 
and 4,000 IU of D3 activity based on the conversion of 0.025 μg of cholecalciferol into one IU (NRC, 1994). 
2
 TBA, tibia bone ash (%); TBS, tibia breaking strength (kg force). 
3












 In conclusion, the combination of both D3 and 25-OH-D3 was more effective than D3 
alone in promoting bone mineralization and enhancing VDS in young broiler chickens fed diets 
with suboptimal levels of Ca and NPP after a live vaccine coccidiosis challenge. The 
supplementation of D3, independent of the source, above NRC (1994) recommendations yielded 
better performance, bone mineralization and VDS in starter broiler chickens fed a low Ca and 
NPP diet and subjected to a live coccidia vaccine challenge. 
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 The accelerated growth of the commercial poultry industry over the last 20 years has led 
to the development of modern poultry strains that are genetically selected for improved feed 
efficiency and higher meat yields. Therefore, it is possible that commercial poultry strains have 
altered their physiology and consecutively, their ability to respond to dietary nutrients. Thus, an 
increasing concern among nutritionists over the last few years regards the need for adapting or 
developing new protocols to evaluate nutrient requirements that are based on current feeding 
strategies and genetic bird strains.  
 Nutritionist and researchers use literature references such as the NRC to establish 
nutritional requirements of poultry. The last revision of the NRC was in 1994 and many of the 
literature referenced can date as early as the 1960s. Therefore, in many cases the NRC nutrient 
recommendations will no longer reflect the current nutritional needs of modern poultry strains.
 As an example, the Vitamin D3 requirement of growing broiler chickens in the NRC 
(1994) was estimated at 200 IU/kg of feed. However, post NRC literature reports suggest that 
dietary supplementation of D3 (up to 20x the 1994 NRC) is necessary for optimal growth and 
prevention of skeletal disorders.  
 To further investigate if the vitamin D3 requirement has changed from the last NRC 
revision in 1994, this dissertation focused on developing a protocol that would precisely estimate 
the vitamin D3 requirement of young growing broilers and would adapt to the current ability of 
meat-type chickens to respond to dietary nutrients. This protocol focused on reducing feed 




methodologies of estimating nutrient requirements; as well as reducing the effect of maternal D3 
found in the egg yolk and increasing the precision of D3 delivery to the chickens.  
 Furthermore, the effect of dietary D3 metabolites such as 25-hydroxycholecalciferol (25-
OH-D3) is rapidly gaining popularity among the commercial poultry industry as they are actively 
seeking for possible dietary “alternatives” to antibiotic growth promoters and ways to enhance 
animal well-being through nutrition. The NRC has very limited information regarding the use of 
feed additives such as exogenous enzymes, probiotics, prebiotics, herbal mixtures, essential oils 
or vitamin metabolites such as 25-OH-D3. Therefore, the second objective of this dissertation 
was to compare the effect of dietary levels of D3 and partial replacement of D3 with 25-OH-D3 
on performance, bone mineralization, intestinal integrity, vitamin D status, and plasma cytokine 
levels of broiler chickens after a live coccidiosis vaccine challenge.  
The vitamin D3 requirement for starter broilers was estimated to be around 500 IU/kg of 
feed when a low Ca (0.75%) and non-phytate phosphorus (0.37%) diet was fed. When an 
industry type nutritionally adequate feed was offered to the chickens the D3 requirement was 
estimated to be around 200 IU/kg of feed for maximum growth and bone mineralization. We 
concluded that nutrient restrictions increased the D3 requirement with respect the NRC (1994) 
but if the diet is nutritionally adequate the vitamin D3 requirement of modern poultry strains is 
still in agreement with the 1994 NRC recommendations.  
 It can be concluded that the vitamin D3 requirement of starter broiler chickens is highly 
influenced by the maternal reserves of D3 found in the egg yolk. Due to the high supplementation 
of D3 to broiler breeders in commercial facilities, the deposition in the egg yolk is high. If a D3-
deficient state is not induced in the chickens the response to dietary D3 will be reduced and 




ensuring the chickens used in D3 requirement studies have a homogenous and preferably low 
vitamin D status so a deficiency can be achieved with a practical broiler diet. 
For the second part of the dissertation it can be concluded that the combination of both D3 
and 25-OH-D3 is more effective than D3 alone in promoting bone mineralization and enhancing 
vitamin D status in young broiler chickens subjected to a live coccidiosis vaccine challenge. The 
use of 25-OH-D3 as a partial replacement of D3 in poultry diets could provide a more effective 
margin of safety in preventing skeletal disorders in poultry and enhance performance. The 
supplementation of D3, independently of the source, above NRC (1994) recommendations 
yielded better performance, bone mineralization and vitamin D status in starter broiler chickens 
subjected to a live coccidiosis vaccine challenge. Thus, dietary supplementation of D3 or a 
combination of D3 plus 25-OH-D3 is an effective nutritional strategy to ameliorate the negative 
effects of intestinal parasites introduced after coccidiosis vaccination. 
 
 
 
 
 
 
 
 
 
 
 
